OBSTRUCTIVE
OBSTRUCTIVE
JAUNDICE
JAUNDICE
HAMED RASHAD
HAMED RASHAD
Professor of surgery Banha faculty of medicine - Egypt
JAUNDICE
JAUNDICE
JA
JA
U
U
N
N
D
D
I
I
C
C
E
E
Anatomy of biliary system
Anatomy of biliary system
JAUNDICE
It is yellowish discoloration of
Skin, mucous membranes, sclera
Due to excess plasma bilirubin
Is not a disease but rather a sign
that can
occur in many different diseases
Normal
range
5-17 m
mol/l
Clinically
obvious
50 mmol/l
(2.5mg/dl)
The differential diagnosis for
yellowing of the skin is limited.
In
addition to jaundice, it includes
Carotenoderma
The use of the drug Quinacrine
Excessive exposure to phenols
in carotenoderma the pigment
is concentrated on the palms,
soles, forehead, and nasolabial
folds. Carotenoderma can be
distinguished from jaundice by
the sparing of the sclerae
Bilirubin Production & Metabolism:
Bilirubin Production & Metabolism:
Formation
of
Bilirubin
Mainly
in
RES
(Spleen)
Conjugation
of
bilirubin
in
Hepatocyte
About 70 to 80% of
the 250 to 300 mg
of bilirubin
produced each day
is derived from the
breakdown of
hemoglobin in
senescent red
blood cells
The remainder
comes from
prematurely
destroyed erythroid
cells in bone
marrow and from
the
turnover of
hemoproteins such
as myoglobin and
cytochromes found
in tissues
throughout the
body.
Excretion
E V Pathway for RBC Scavenging
E V Pathway for RBC Scavenging
Liver, Spleen &
Bone marrow
Hemoglobin
Globin
Amino acids
Amino acid pool
Heme Bilirubin
Fe2+
Excreted
Phagocytosis & Lysis
Through Liver
6
www.drsarma.in
BILE SALTS
BILE SALTS
These are synthesized by the hepatic cells. Cholic acid
These are synthesized by the hepatic cells. Cholic acid
is formed from cholesterol and is conjugated with
is formed from cholesterol and is conjugated with
either taurine or glycine to form the bile salts –
either taurine or glycine to form the bile salts –
glcyocholic and taurocholic acids.At the pH of bile
glcyocholic and taurocholic acids.At the pH of bile
7.3-7.7 taurocholate and glycocholate exist as anions.
7.3-7.7 taurocholate and glycocholate exist as anions.
They are water soluble and are necessary for the
They are water soluble and are necessary for the
digestion of fats.
digestion of fats.
In obstructive jaundice they are regurgitated into blood
In obstructive jaundice they are regurgitated into blood
and are filtered by the kidneys and so are present in
and are filtered by the kidneys and so are present in
urine
urine
I
I
Van den Burgh Test
Van den Burgh Test
 When a mixture of sulphanilic acid, HCl, and sodium
When a mixture of sulphanilic acid, HCl, and sodium
nitrite is added to sierum containing an excess of
nitrite is added to sierum containing an excess of
bilirubin glucuronide a reddish violet colour results max
bilirubin glucuronide a reddish violet colour results max
in 30secs. This is called the Direct reaction
in 30secs. This is called the Direct reaction
 When the reagents are mixed with serum containing an
When the reagents are mixed with serum containing an
excess of bilirubin no colour develops until alcohol is
excess of bilirubin no colour develops until alcohol is
added whereupon the reddish-violet colour appears.
added whereupon the reddish-violet colour appears.
DEFINITION
DEFINITION
 Yellow discolouration of body tissues
Yellow discolouration of body tissues

excess circulating bilirubin
excess circulating bilirubin
 Normal bilirubin
Normal bilirubin
0.2-1.2mg%(5-17umol/l)
0.2-1.2mg%(5-17umol/l)
Jaundice
Jaundice 
 2-3mg% or (>40umol/l)
2-3mg% or (>40umol/l)
S.cl.jaun.
S.cl.jaun. 
 1-2mg%
1-2mg%
 Best observed
Best observed
 sites cont. elast. Tissues
sites cont. elast. Tissues
eg.: sclera, skin, mm
eg.: sclera, skin, mm
Surgical
Surgical
Pathophysiolology
Pathophysiolology
CLASSIFICATION
CLASSIFICATION
 No satisfactory classification
No satisfactory classification
 Classically:
Classically:
Prehepatic (excess dest., hlytic)
Prehepatic (excess dest., hlytic)
Hepatic (liver damage)
Hepatic (liver damage)
Post hepatic (obst. Or surgical)
Post hepatic (obst. Or surgical)
(stasis without a lesion requiring surg..
(stasis without a lesion requiring surg..
 Conj. Or Unconj.:
Conj. Or Unconj.: little cl. Value (often mixed)
little cl. Value (often mixed)
 D
D
 Surgical or Non-surgical
Surgical or Non-surgical
CLASSIFICATION
CLASSIFICATION
 Old standard classification
Old standard classification :
: pre
prehepatic
hepatic (hemolytic)
(hemolytic) ,
,
hepatic
hepatic (hepatocellular )&
(hepatocellular )& post
posthepatic
hepatic (obstructive )
(obstructive )
 New classification
New classification :
: cholestatic
cholestatic
(inrta & extra hepatic cholestasis)
(inrta & extra hepatic cholestasis)
VS
VS non-cholestatic
non-cholestatic
(hepatocellular insufficiency)
(hepatocellular insufficiency)
Jaundice – Classification
Jaundice – Classification
 Normal Serum Bilirubin (SB) is 0.3 to 1.0 mg%
Normal Serum Bilirubin (SB) is 0.3 to 1.0 mg%
 Jaundice is increased levels of SB > 1.0 mg%
Jaundice is increased levels of SB > 1.0 mg%
 Over production of Bilirubin (Hemolytic)
Over production of Bilirubin (Hemolytic)
 From hemolysis of RBC
From hemolysis of RBC
 Lysis of RBC precursors – Ineffective erythropoesis
Lysis of RBC precursors – Ineffective erythropoesis
 Impaired hepatic function (Hepatitic)
Impaired hepatic function (Hepatitic)
 Hepatocellular dysfunction in handling bilirubin
Hepatocellular dysfunction in handling bilirubin
 Uptake, Metabolism and Excretion of bilirubin
Uptake, Metabolism and Excretion of bilirubin
 Obstruction to bile flow (Obstructive)
Obstruction to bile flow (Obstructive)
 Intrahepatic cholestasis
Intrahepatic cholestasis
 Extrahepatic Obstruction (Surgical Jaundice
Extrahepatic Obstruction (Surgical Jaundice)
)
13
www.drsarma.in
Etiology Of Jaundice:
Etiology Of Jaundice:
Increase
of
production
Impaired
of
Clearance
Pre-Hepatic
Pre-Hepatic
 Haemolytic anaemia – hereditary spherocytosis,
Haemolytic anaemia – hereditary spherocytosis,
sickle cell, thalassaemia, Gilbert’s syndrome
sickle cell, thalassaemia, Gilbert’s syndrome
 High levels of unconjugated bilirubin, normal
High levels of unconjugated bilirubin, normal
LFTs, raised reticulocytes
LFTs, raised reticulocytes
 Investigate further with blood film and
Investigate further with blood film and
autoantibody screen
autoantibody screen
Hepatic
Hepatic
 Hepatic injury – viral hepatitis, sclerosis,
Hepatic injury – viral hepatitis, sclerosis,
cirrhosis, poisons, drugs
cirrhosis, poisons, drugs
 Bilirubin tends to be conjugated, (jaundice
Bilirubin tends to be conjugated, (jaundice
occurs out of failure to excrete, not conjugate)
occurs out of failure to excrete, not conjugate)
 Abnormal LFTs (raised ALT/AST)
Abnormal LFTs (raised ALT/AST)
 Investigate further with viral titres, USS, liver
Investigate further with viral titres, USS, liver
biopsy
biopsy
Post-Hepatic (Your Turn)
Post-Hepatic (Your Turn)
Wall Lumen Outside Lumen
Sclerosing cholangitis
Gallstones Tumour (pancreatic,
ampullary, duodenal)
Benign stricture Schistosomiasis Chronic pancreatitis
Cholangiocarcinoma Clonorchis Portal lymphadenopathy
•Raised conjugated bilirubin (absorbed from biliary tree)
•Decreased urinary urobilinogen (bilirubin does not make it to
the small bowel)
•Obstructed LFTs (raised ALP and GGT)
•Further investigation with USS, and then ERCP/CT as appropriate
Lab Diagnosis of Jaundice – D.D
Lab Diagnosis of Jaundice – D.D
18
Features
Prehepatic
(Heamolytic)
Intrahepatic
(Hepatocellular)
Posthepatic
(Obstructive)
Unconjugated ↑ Normal Normal
Conjugated Normal ↑ ↑
AST or ALT Normal ↑ ↑ Normal
Alkaline phos.
and GGT
Normal Normal ↑ ↑
Urine bilirubin Absent Present Increased
Urobilinogen Increased Present Absent
www.drsarma.in
OBSTRUCTIVE
OBSTRUCTIVE
JAUNDICE
JAUNDICE
Definition
Definition
 Jaundice is the yellowish pigmentation of the skin, the
Jaundice is the yellowish pigmentation of the skin, the
conjunctival membranes over the sclerae, and other mucous
conjunctival membranes over the sclerae, and other mucous
membranes caused by hyperbilirubinemia.
membranes caused by hyperbilirubinemia.
 Total serum bilirubin values are normally 0.2-1.2 mg/dL.
Total serum bilirubin values are normally 0.2-1.2 mg/dL.
Jaundice may not be clinically recognizable until levels are at
Jaundice may not be clinically recognizable until levels are at
least 3 mg/dL.
least 3 mg/dL.
 Jaundice is not a diagnosis.
Jaundice is not a diagnosis.
 Surgical jaundice is any jaundice amenable to surgical treatment.
Surgical jaundice is any jaundice amenable to surgical treatment.
The majority are due to extrahepatic biliary obstruction.
The majority are due to extrahepatic biliary obstruction.
 Not all obstructive jaundice is surgical jaundice e.g hepatitis and
Not all obstructive jaundice is surgical jaundice e.g hepatitis and
not all surgical jaundice is due to
not all surgical jaundice is due to obstruction e.g congenital
obstruction e.g congenital
spherocytosis
spherocytosis
Epidemiology
Epidemiology
RACE
RACE
•
• The racial predilection depends on the cause of the biliary
The racial predilection depends on the cause of the biliary
obstruction.
obstruction.
•
• Gallstones are the most common cause of biliary obstruction.
Gallstones are the most common cause of biliary obstruction.
•
• Persons of Hispanic origin and Northern Europeans have a
Persons of Hispanic origin and Northern Europeans have a
higher risk of gallstones compared to people from Asia and
higher risk of gallstones compared to people from Asia and
Africa.
Africa.
•
• Native Americans (particularly Pima Indians)have a lifetime
Native Americans (particularly Pima Indians)have a lifetime
chance of developing gallstones as high as 80%.
chance of developing gallstones as high as 80%.
Epidemiology
Epidemiology
SEX
SEX
•
• Women are much more likely to develop gallstones than men.
Women are much more likely to develop gallstones than men.
•
• This increased risk is likely caused by the effect of estrogen on
This increased risk is likely caused by the effect of estrogen on
the liver, causing it to remove more cholesterol from the blood
the liver, causing it to remove more cholesterol from the blood
and diverting it into the bile.
and diverting it into the bile.
Pathophysiolog
Pathophysiology
y
 To better understand these disorders, a brief discussion of the normal
To better understand these disorders, a brief discussion of the normal
structure and function of the biliary tree is needed.
structure and function of the biliary tree is needed.
 Bile is the exocrine secretion of the liver and is produced continuously by
Bile is the exocrine secretion of the liver and is produced continuously by
hepatocytes. It contains cholesterol and waste products, such as bilirubin
hepatocytes. It contains cholesterol and waste products, such as bilirubin
and bile salts, which aid in the digestion of fats. Half the bile produced
and bile salts, which aid in the digestion of fats. Half the bile produced
runs directly from the liver into the duodenum via a system of ducts,
runs directly from the liver into the duodenum via a system of ducts,
ultimately draining into the common bile duct (CBD). The remaining 50%
ultimately draining into the common bile duct (CBD). The remaining 50%
is stored in the gallbladder.
is stored in the gallbladder.
 In response to a meal, this bile is released from the gallbladder via the
In response to a meal, this bile is released from the gallbladder via the
cystic duct, which joins the hepatic ducts from the liver to form the CBD.
cystic duct, which joins the hepatic ducts from the liver to form the CBD.
The CBD courses through the head of the pancreas for approximately 2 cm
The CBD courses through the head of the pancreas for approximately 2 cm
before passing through the ampulla of Vater into the duodenum
before passing through the ampulla of Vater into the duodenum
Obstructive Jaundice
Causes
Causes
 Causes of biliary obstruction can be separated into
Causes of biliary obstruction can be separated into
intrahepatic and extrahepatic.
intrahepatic and extrahepatic.
 intrahepatic causes are most commonly hepatitis and
intrahepatic causes are most commonly hepatitis and
cirrhosis, Drugs e.g thiazides, chlorpromazine,
cirrhosis, Drugs e.g thiazides, chlorpromazine,
augmentin, etc
augmentin, etc
 Extrahepatic causes may be further subdivided into
Extrahepatic causes may be further subdivided into
intrinsic, intraluminal, and extrinsic
intrinsic, intraluminal, and extrinsic
Obstructive Jaundice etiology and management  the lect.ppt
Obstruction of common
bile duct leading to pain
& jaundice
May Complicate to
Charcot’s Triad:
1-Pain
2-Jaundice
3-Fever
Reynold’s Pentad:
1-Pain
2-Jaundice
3-Fever
4-Altered Mental State
5-Shock
Abdominal Ex:
1-Gall Bladder: in 80%Not Distended
When gall bladder be distended??
Murphy’s sign +ve
2-Liver:Enlarged?????
Incidence According to large study
Incidence According to large study
Causes of Cholestatic Jaundice
Causes of Cholestatic Jaundice
29
Intrahepatic
Intrahepatic Extrahepatic
Extrahepatic
Acute liver injury, Viral hepatitis
Acute liver injury, Viral hepatitis Choledocholithiasis
Choledocholithiasis
Alcohol hepatitis, Drugs
Alcohol hepatitis, Drugs Stone obstructing CBD, CD
Stone obstructing CBD, CD
Chronic liver injury, PBC, PSC
Chronic liver injury, PBC, PSC Biliary strictures
Biliary strictures
Autoimmune cholangiopathy
Autoimmune cholangiopathy Cholangiocarcinoma
Cholangiocarcinoma
Drugs, Total parenteral nutrition
Drugs, Total parenteral nutrition Pancreatic carcinoma
Pancreatic carcinoma
Systemic infection, Postoperative
Systemic infection, Postoperative Pancreatitis, Periampullary Ca
Pancreatitis, Periampullary Ca
Benign causes, Amyloid, lymphoma
Benign causes, Amyloid, lymphoma PSC, Biliary atresia, duct cysts
PSC, Biliary atresia, duct cysts
www.drsarma.in
Aetiology of obstructive jaundice
Aetiology of obstructive jaundice
Common
Common
 Common bile duct
stones
 Carcinoma of the head of
pancreas
 Malignant porta
hepatis lymph nodes
 Ampullary
carcinoma

Pancreatitis ,pseudocysts
 Benign strictures
 Iatrogenic, trauma
 Recurrent cholangitis
 Mirrizi's syndrome
 Sclerosing cholangitis
 Cholangiocarcinoma
 Biliary atresia
 Choledochal cysts
Drugs causing Cholestasis
Drugs causing Cholestasis
www.drsarma.in 31
 Anabolic steroids (testosterone, norethandrolone)
Anabolic steroids (testosterone, norethandrolone)
 Antithyroid agents (methimazole)
Antithyroid agents (methimazole)
 Azathioprine (Immunosuppressive drug)
Azathioprine (Immunosuppressive drug)
 Chlorpromazine HCI (Largactil)
Chlorpromazine HCI (Largactil)
 Clofibrate, Erythromycin estolate
Clofibrate, Erythromycin estolate
 Oral contraceptives (containing estrogens)
Oral contraceptives (containing estrogens)
 Oral hypoglycemics (especially chlorpropamide)
Oral hypoglycemics (especially chlorpropamide)
DDx: Conjugated Bilirubinemia
DDx: Conjugated Bilirubinemia
 Intrahepatic cholestasis/impaired excretion
Intrahepatic cholestasis/impaired excretion
 Hepatitis (viral, alcoholic, and non-alcoholic)
Hepatitis (viral, alcoholic, and non-alcoholic)
 Any cause of hepatocellular injury
Any cause of hepatocellular injury
 Primary biliary cirrhosis or end-stage liver dz
Primary biliary cirrhosis or end-stage liver dz
 Sepsis and hypoperfusion states
Sepsis and hypoperfusion states
 TPN
TPN
 Pregnancy
Pregnancy
 Infiltrative dz: TB, amyloid, sarcoid, lymphoma
Infiltrative dz: TB, amyloid, sarcoid, lymphoma
 Drugs/toxins i.e. chlorpromazine, arsenic
Drugs/toxins i.e. chlorpromazine, arsenic
 Post-op patient or post-organ transplantation
Post-op patient or post-organ transplantation
 Hepatic crisis in sickle cell disease
Hepatic crisis in sickle cell disease
DDx: Obstructive Jaundice
DDx: Obstructive Jaundice
Obstructive Jaundice– extrahepatic cholestasis
Obstructive Jaundice– extrahepatic cholestasis
 Choledocholithiasis
Choledocholithiasis (CBD or CHD stone)
(CBD or CHD stone)
 Cancer
Cancer (peri-ampullary or cholangioCA)
(peri-ampullary or cholangioCA)
 Strictures
Strictures after invasive procedures
after invasive procedures
 Acute and chronic
Acute and chronic pancreatitis
pancreatitis
 Primary sclerosing cholangitis (PSC)
Primary sclerosing cholangitis (PSC)
 Parasitic infections
Parasitic infections
 Ascaris lumbricoides, liver flukes
Ascaris lumbricoides, liver flukes
Just remember top 5 (not parasites)
Just remember top 5 (not parasites)
Common causes
Common causes
 Gallstones and carcinoma of pancreas
Gallstones and carcinoma of pancreas
 Rare cholangiocarcinoma, pancreatitis
Rare cholangiocarcinoma, pancreatitis
 USS > 90% gallstones
USS > 90% gallstones
 No gallstones or significant pain – CT
No gallstones or significant pain – CT
 Avoid knee-jerk ERCP
Avoid knee-jerk ERCP
 Serial LFTs vital – fluctuant or progressive
Serial LFTs vital – fluctuant or progressive
 GS in GB but history equivocal - MRCP
GS in GB but history equivocal - MRCP
Haemolytic Hepatocellular Obstructive
Long standing Constitutional
symptoms
Progressive
Low bilirubin levels Blood transfusion High bilirubin
levels
Anaemia Epidemic Pruritus
hepatosplenomegaly Exposure to
toxins
Wt. loss/malena
Ulcerations over legs Septicemia Abdominal lump
Splenomegaly Colour of stools
Previous biliary
surgery
ERCP
ERCP
Ampullary carcinoma
stone
Clinical Picture & Diagnosis
Clinical Picture & Diagnosis
Diagnosis established by the triad:
Diagnosis established by the triad:
HISTORY
HISTORY
EXAMINATION
EXAMINATION
INVESTIGATIONS
INVESTIGATIONS
History of presenting illness
History of presenting illness
 •
• Gradually progressive jaundice
Gradually progressive jaundice
 •
• Recurrent episodes of itching
Recurrent episodes of itching
 •
• White stools for the last 2 months
White stools for the last 2 months
 •
• Dark yellow urine
Dark yellow urine
 •
• Generalized weakness & fatigability- 6
Generalized weakness & fatigability- 6
months
months
 •
• Weight loss in the last 1 year
Weight loss in the last 1 year
 •
• Reduced appetite
Reduced appetite
 •
• No fever
No fever
H/o past illness
• No h/o DM, HT, TB, Chest pain
• No previous surgery(no history of
cholelithiasis)
Personal History
• Decreased appetite with pale stools
• Normal bladder habits but deep
yellowish
• Smoker – 25 yrs
• Non-alcoholic
General Physical Examination
General Physical Examination
–
– Pulse 88/min, BP 110/70
Pulse 88/min, BP 110/70
–
– anemia +, Jaundice ++
anemia +, Jaundice ++
–
– No Lymphadenopathy
No Lymphadenopathy
–
– Scratch marks
Scratch marks
Per abdomen
Per abdomen
–
– Soft non-tender
Soft non-tender
–
– Gall bladder palpable
Gall bladder palpable
–
– No free fluid
No free fluid
Clinical Picture & Diagnosis
Clinical Picture & Diagnosis
 A. HISTORY:
A. HISTORY:
Age, sex, parity, habits
Age, sex, parity, habits
Occupation
Occupation 
sheep farmer
sheep farmer
hydatid
hydatid
Fam.hist.
Fam.hist.
 anae.,stones,splenect.(her.sph.)
anae.,stones,splenect.(her.sph.)
Pers.Hist.:Histort of bil.surg.
Pers.Hist.:Histort of bil.surg.
stricture/resid.stone
stricture/resid.stone
alcohol
alcohol 
cirrhosis, chr. Pancreatitis.
cirrhosis, chr. Pancreatitis.
drugs
drugs
chloropromazine hlysis/stasis
chloropromazine hlysis/stasis
Clinical Picture & Diagnosis
Clinical Picture & Diagnosis
Symptoms:
Symptoms:
-Jaundice:
-Jaundice: sudden
sudden:=stones,
:=stones, grad
grad=cirrho,,panc ca,
=cirrho,,panc ca,
progressive
progressive=malignant i
=malignant intermittent
ntermittent=stone,ca amp.
=stone,ca amp.
-Pain:
-Pain:painless
painless
-Fever & chills:
-Fever & chills: stasis & infection
stasis & infection
-Pruritis:
-Pruritis: bile salt irrit. Of cut nerves
bile salt irrit. Of cut nerves
-Wt. loss:
-Wt. loss: malig. / chr. Hep-cellular.
malig. / chr. Hep-cellular.
Obstructive Jaundice etiology and management  the lect.ppt
Clinical Picture & Diagnosis
Clinical Picture & Diagnosis
 B.EXAMINATION(signs)
B.EXAMINATION(signs)
/ 
/ 
General Local
General Local 

Depth of J
Depth of J.
.
 Lem. yellow=hlyt ,orange=Hep.cell deep=
Lem. yellow=hlyt ,orange=Hep.cell deep=
obst.
obst.
Anaemia
Anaemia
 malig./cirrhosis/ hlytic
malig./cirrhosis/ hlytic
L failure
L failure
palm erythema, spid. nevi,foetor hep
palm erythema, spid. nevi,foetor hep
gynecom., test atrophy, clubbing, flapping trermor
gynecom., test atrophy, clubbing, flapping trermor
Supra. LN
Supra. LN
metas.
metas. Skin
Skin
scratches
scratches Fever
Fever
itis,sept.
itis,sept.
Clinical Picture & Diagnosis
Clinical Picture & Diagnosis
Local signs:
Local signs:
Scar
Scar
 previous surg
previous surg. Caput med.
. Caput med.
PHT
PHT
Site of tend.(Murphy’s) GB
Site of tend.(Murphy’s) GB

 Liver
Liver 
 Hard nod= 2ries , small nod=
Hard nod= 2ries , small nod=
cirrhosis,smooth=cholestasis,tender=hitits
cirrhosis,smooth=cholestasis,tender=hitits

Spleen
Spleen 
 cong hlytic an, PHT
cong hlytic an, PHT
MASS
MASS
 hard irreg
hard irreg. Ascites
. Ascites 
malig & liver
malig & liver
PR
PR
colour ,1ry, deposits.
colour ,1ry, deposits.
Investigations
Investigations
 C. INVESTIGATIONS
C. INVESTIGATIONS:
:
Aim
Aim 
 define aetiology, assess cond.,
define aetiology, assess cond.,
proper ttt.
proper ttt.
LABORATORY
LABORATORY
IMAGING
IMAGING
ENDOSCOPIC
ENDOSCOPIC
HISTOPATH.
HISTOPATH.
SPECIFIC
SPECIFIC
Laboratory:
Laboratory:
LABORATORY:
LABORATORY:
1
1.
. CBC
CBC:
: 
WBC= cholangitis, anaem=Malig.
WBC= cholangitis, anaem=Malig.
spherocytosis, RC fragility, reticulocytes
spherocytosis, RC fragility, reticulocytes
glucose tol. Curve
glucose tol. Curve 
 dist in panc ca.
dist in panc ca.
urine
urine
 liquorice,
liquorice, 
bilirubin in ob, bile salts,
bilirubin in ob, bile salts,
no urobilinogen
no urobilinogen
stool
stool: clay colour, no or
: clay colour, no or 
stercobilin,
stercobilin,

fat, occult bld=malig.
fat, occult bld=malig.
Laboratory
Laboratory
 2.Liver Function tests:
2.Liver Function tests:

 Serum bilirubin
Serum bilirubin 
 total & direct> 20%
total & direct> 20%

Alk. Phosph.
Alk. Phosph. 
 35 KAU= calc ./ 50KAU= malig
35 KAU= calc ./ 50KAU= malig

Proth act.
Proth act. 
 Cholestatic & H cellular
Cholestatic & H cellular
correctable by vit K
correctable by vit K

ALT & ALA enz
ALT & ALA enz
5 nucleotidase &
5 nucleotidase & 
-GT
-GT
Laboratory
Laboratory
 3. Serum amylase:
3. Serum amylase:
N
N 
 calc.,
calc., 
pancitis. &malig.
pancitis. &malig.
4. Tumours markers:
4. Tumours markers:
+ve in malig.
+ve in malig.
 CA 19.9, CEA, panc.
CA 19.9, CEA, panc.
oncofoetal antigen
oncofoetal antigen
IMAGING & ENDOSCOPY
IMAGING & ENDOSCOPY
-ULTRA SOUND
-ULTRA SOUND
-CT & MRI
-CT & MRI
-Ba meal
-Ba meal
-CHOLANGIOGRAPHY
-CHOLANGIOGRAPHY
ERCP/PTC/MRCP
ERCP/PTC/MRCP
- D. LAPAROSCOPY
- D. LAPAROSCOPY
Plain x-ray abdomen
Plain x-ray abdomen
IMAGING & ENDOSCOPY
IMAGING & ENDOSCOPY
-
-ULTRASOUND
ULTRASOUND:
:
1 or X stones, intra or extra hep bil.dil
1 or X stones, intra or extra hep bil.dil
CBD caliber & thickness
CBD caliber & thickness
(
(>10mmw contrast or >7mm wout)
>10mmw contrast or >7mm wout)

panc. Head/ T at porta hep./Ascites/liver
panc. Head/ T at porta hep./Ascites/liver
-
-CT & MRI
CT & MRI:
: panc & retroperit.
panc & retroperit.
-
-Ba meal
Ba meal (
(hypot.duod)
hypot.duod)
wide D curve & inv 3 of ca amp
wide D curve & inv 3 of ca amp
CT SCAN
CT SCAN
IMAGING & ENDOSCOPY
IMAGING & ENDOSCOPY
 CHOLANGIOGRAPHY:
CHOLANGIOGRAPHY:
ERCP
ERCP 
low CBD
low CBD
advantage:
advantage:
D visualise bili passage & panc d
D visualise bili passage & panc d (db
(db
duct sign)
duct sign)
detect any path.
detect any path.
cytology
cytology
ttt sphincterotomy, stone extra,
ttt sphincterotomy, stone extra,
NB drainage, stenting
NB drainage, stenting
comps: pitis, perforation, bleeding
comps: pitis, perforation, bleeding
Obstructive Jaundice etiology and management  the lect.ppt
Obstructive Jaundice etiology and management  the lect.ppt
IMAGING & ENDOSCOPY
IMAGING & ENDOSCOPY
 PTC:
PTC: replaced by ERCP & MRCP
replaced by ERCP & MRCP
DIAGNOSIS
DIAGNOSIS
Stone
Stone 
 smooth crescent, filling defect
smooth crescent, filling defect
Stricture
Stricture 
 smooth tapered CBD
smooth tapered CBD
CBDT
CBDT 
 irreg. defect
irreg. defect
Ca head
Ca head 
 obst & dil.
obst & dil.
COMPS
COMPS
Peritonitis, he, cholangitis
Peritonitis, he, cholangitis
IMAGING & ENDOSCOPY
IMAGING & ENDOSCOPY
CBD filling defect (stone)
CBD filling defect (stone) Choledochal Cyst
Choledochal Cyst
PTC
IMAGING & ENDOSCOPY
IMAGING & ENDOSCOPY
 MRCP
MRCP
non invasive
non invasive
accurate diag.
accurate diag.
non operator dependent
non operator dependent
non therapeutic
non therapeutic
MRCP
MRCP

Non Contrast Angiography
Non Contrast Angiography 

MRCP
MRCP
Excellent visualization of
Excellent visualization of
intra luminal lesions , as
intra luminal lesions , as
well as clear anatomical
well as clear anatomical
imaging
imaging
SPECIAL TESTS
SPECIAL TESTS
SPECIAL TESTS:
SPECIAL TESTS:
 if biochemical point to:
if biochemical point to:
parenchymal
parenchymal
 liver biopsy & immunof.
liver biopsy & immunof.
obst J.:
obst J.: 
US
US 
D dil i.hep D
D dil i.hep D
GB, CBD, panc,Liver
GB, CBD, panc,Liver
CT
CT
panc lesion, obese, gases
panc lesion, obese, gases
SPECIAL TESTS
SPECIAL TESTS
 If Dilated i.hep. Duct:
If Dilated i.hep. Duct:
PTC(
PTC(coag profile,antibs)
coag profile,antibs) 
D & drain
D & drain
 Non dilated ducts or equivocal US
Non dilated ducts or equivocal US
ERCP + sphincterotomy or stone
ERCP + sphincterotomy or stone
removal
removal
Physical examination
Physical examination
 General : signs of liver cell failure
General : signs of liver cell failure
Spider naevi, palmer erythema,scanty axillary and pubic
Spider naevi, palmer erythema,scanty axillary and pubic
hair foetor hepaticus ,neurological changes
hair foetor hepaticus ,neurological changes
supraclavicular swelling(Virchow’s sign) scratch marks
supraclavicular swelling(Virchow’s sign) scratch marks
 Ascitis (associated ALD, Malignant)
Ascitis (associated ALD, Malignant)
 Hepatosplenomegaly Splenomegaly may be due to splenic
Hepatosplenomegaly Splenomegaly may be due to splenic
vein thrombosis secondary to pancreatic malignancy
vein thrombosis secondary to pancreatic malignancy
 Palpable Gall bladder ,Abdominal lump
Palpable Gall bladder ,Abdominal lump
Jaundice with distended palpable Gall bladder
Periampullary/Ca head of pancreas
Cholangiocarcinoma of lower CBD
Carcinoma Gallbladder
Jaundice without palpable gall bladder
Choledocholithiasis (shrunken Gall bladder)
Hilar cholangiocarcinoma
Nodes at porta hepatis
Courvoisier’s Law
Courvoisier’s Law
 If in a jaundiced
patient,the gall bladder is
palpable,
the case is not of stone
impacted in CBD for
previous cholecystitis
existed when stone was in
the gall bladder rendered
gall bladder fibrotic and
incapable of dilatation
Exceptions to Courvoisier’s law
Exceptions to Courvoisier’s law
 Double impaction
Double impaction
 Oriental
Oriental
Cholangiohepatitis
Cholangiohepatitis
 Earlier
Earlier
Cholecystectomy
Cholecystectomy
 Malignant nodes at
Malignant nodes at
Porta hepatis
Porta hepatis
Choledocholithiasi
s
Clinical Features
Cholangitis: Pain,Fever Jaundice,Shock
Cloudy Sensorium (Reynold’s Pentad)
Backache due to pancreatitis acholic stools pruritus
,high colored urine malnutrition and weight loss
Alkaline Phosphatase,raised liver Enzymes in
Cholangitis Leukocytosis
Real-Time Mode Ultrasound is the single most important
Investigation
Round Worm
CBD Stone
Clinical classification Of Obstructive
Clinical classification Of Obstructive
Jaundice
Jaundice
(
(Benjamin Classification)
Benjamin Classification)
Type I: Complete obstruction
Type I: Complete obstruction
Classical symptoms with
Classical symptoms with
biochemical changes
biochemical changes
Tumors: Ca. head of
Tumors: Ca. head of
Pancreas
Pancreas
Ligation of the CBD
Ligation of the CBD
Cholangiocarcinoma
Cholangiocarcinoma
Parenchymal Liver
Parenchymal Liver
diseases
diseases
Type II: Intermittent obstruction
Type II: Intermittent obstruction
•
• Symptoms and typical
Symptoms and typical
biochemical changes
biochemical changes
•
• But jaundice may or may
But jaundice may or may
not be present
not be present
Choledocholithiasis
Choledocholithiasis
Periampullary tumor
Periampullary tumor
Duodenal diverticula
Duodenal diverticula
Choledochal Cyst
Choledochal Cyst
Papillomas of the bile duct
Papillomas of the bile duct
Intra biliary parasites
Intra biliary parasites
Hemobilia
Hemobilia
TYPE III: Chronic incomplete obstruction
TYPE III: Chronic incomplete obstruction
With or without classical symptoms but
With or without classical symptoms but
pathological changes are present in the
pathological changes are present in the
bile duct and liver
bile duct and liver
Strictures of the CBD
Strictures of the CBD
- Congenital
- Congenital
- Traumatic
- Traumatic
- Sclerosing cholangitis
- Sclerosing cholangitis
- Post radiotherapy
- Post radiotherapy
Stenosed biliary enteric anastamosis
Stenosed biliary enteric anastamosis
Cystic fibrosis
Cystic fibrosis
Chronic pancreatitis ERCP
Chronic pancreatitis ERCP
Stenosis of the Sphincter of Od
Stenosis of the Sphincter of Od
showing distal common
showing distal common
bile duct stricture
bile duct stricture
TYPE IV: Segmental Obstruction
TYPE IV: Segmental Obstruction
one or more segment of the intrahepatic biliary tract
one or more segment of the intrahepatic biliary tract
is obstructed
is obstructed
Traumatic
Traumatic
Sclerosing cholangitis
Sclerosing cholangitis
Intra hepatic stones
Intra hepatic stones
Cholangiocarcinoma
Cholangiocarcinoma
Pathophysiology Of
Pathophysiology Of
Obstructive Jaundice
Obstructive Jaundice
Obstructive
Obstructive
jaundice is a
jaundice is a
condition in which
condition in which
there is blockage of
there is blockage of
the flow of bile out
the flow of bile out
of the liver. This
of the liver. This
results in an
results in an
overflow of bile and
overflow of bile and
its by-products into
its by-products into
the blood, and bile
the blood, and bile
excretion from the
excretion from the
body is incomplete
body is incomplete
 Hepatic functions
Hepatic functions
- Protein synthesis
- Protein synthesis, -
, - Reticulo-endothelial function -
Reticulo-endothelial function -
Hepatic metabolism Coagulation defect..
Hepatic metabolism Coagulation defect..increased
increased
prothrombin time(Decreased absroption of fat solube
prothrombin time(Decreased absroption of fat solube
vitamins A,D,E,
vitamins A,D,E,K
K(decreased factor XI ,XII ,platelets)
(decreased factor XI ,XII ,platelets)
 Renal functions - Renal vasoconstriction -
Renal functions - Renal vasoconstriction -
Activation of complement system causing
Activation of complement system causing peritubular
peritubular
and glomerular fibrin deposition leading to tubular and
and glomerular fibrin deposition leading to tubular and
cortical necrosis
cortical necrosis
 Cardiovascular effects -Decreased peripheral vascular
Cardiovascular effects -Decreased peripheral vascular
resistance - Bradycardia due to direct effect of bile
resistance - Bradycardia due to direct effect of bile
salts on SA node - Decreased cardiac contractability
salts on SA node - Decreased cardiac contractability
Delayed wound healing due to defective synthesis of
Delayed wound healing due to defective synthesis of
collagen
collagen
ROUTINE
ROUTINE Investigations
Investigations
 Haemoglobin usually decreased in case of malignancy
Haemoglobin usually decreased in case of malignancy
 •
• Rfts are usually arranged
Rfts are usually arranged
BIOCHEMICAL PROFILE
BIOCHEMICAL PROFILE
1. Conjugated bilirubin> increased
1. Conjugated bilirubin> increased
2. Urine bilirubin +
2. Urine bilirubin +
3. Urobilinogen will be absent
3. Urobilinogen will be absent
4. S.ALK PHOSPH RAISED
4. S.ALK PHOSPH RAISED (most sensitive, levels are
(most sensitive, levels are
elevated in nearly 100 % of patients with extrahepatic obstruction
elevated in nearly 100 % of patients with extrahepatic obstruction
except in some cases of intermittent obstruction. Values are
except in some cases of intermittent obstruction. Values are
usually greater than 3 times the upper limit of the reference
usually greater than 3 times the upper limit of the reference
range, and in most typical cases, they exceed 5 times the upper
range, and in most typical cases, they exceed 5 times the upper
limit)
limit)
BIOCHEMICAL PROFILE
BIOCHEMICAL PROFILE
5. GAMMA–GLUTAMYL TRANSPEPTIDASE(GGT) is a
5. GAMMA–GLUTAMYL TRANSPEPTIDASE(GGT) is a
sensitive marker of biliary tract disease is raised 6.5’nucleotidase
sensitive marker of biliary tract disease is raised 6.5’nucleotidase
is raised and it’s more specific
is raised and it’s more specific
7. ALT AST may rise
7. ALT AST may rise
8. Albumin decreased
8. Albumin decreased
9 . PT prolonged clotting factor decreased
9 . PT prolonged clotting factor decreased
10. RFTs are usually impaired
10. RFTs are usually impaired
Investigations
Investigations
Liver Function Tests
Alk.Phos.
Direct Hyperbilirubinemia
Serum Proteins
Normal Enzymes
Absent Urobilinogen in urine
Prolonged P.T.which returns to normal
after Vit.K admin.
Tumor markers like CA 19-9
Intra/Extra? Ultrasound Examination
C.T.
MRCP/ERCP
Site:
USG
ERCP
MRCP
EUS
Radiology
Radiology
• IMAGING GOALS
To confirm the presence of an extrahepatic obstruction

To determine the level of the obstruction, to identify the

specific cause of the obstruction
To provide complementary information relating to the

underlying diagnosis (eg., Staging information in cases of
malignancy).
What is the best therapeutic approach?

– More sensitive than CT for gallbladder stones and
other pathology of gallbladder
– Sensitive for dilated ducts (Dilation of the
extrahepatic (>10 mm) or intrahepatic (>4 mm) bile
ducts suggests biliary obstruction.)
– Liver parenchymal mass and Mets
– Portable, cheap, no radiation,
– But it is operator dependant
-- Result is affected by bowel gas and Obesity.
Ultrasound Abdomen
Ultrasound Abdomen
Spiral CT Scan
Spiral CT Scan
 Contrast-enhanced triple phase helical abdominal CT scan. This should be
Contrast-enhanced triple phase helical abdominal CT scan. This should be
carried out with thin cuts to provide arterial (3mm cuts) and venous phase (3
carried out with thin cuts to provide arterial (3mm cuts) and venous phase (3
or 5mm cuts) cross sectional imaging Hypo dense lesion ,Dilated CBD and
or 5mm cuts) cross sectional imaging Hypo dense lesion ,Dilated CBD and
PD with or without pancreatic mass
PD with or without pancreatic mass
 Accurate assessment of spread,involvement of vessels Hepatic mets free
Accurate assessment of spread,involvement of vessels Hepatic mets free
fluid False +ve (10%)focal pancreatitis ,sarcoidosis Tuberculosis, lymphoma
fluid False +ve (10%)focal pancreatitis ,sarcoidosis Tuberculosis, lymphoma
secondary tumors
secondary tumors.
.
 MRI does not score over CT. Hypointense T1 weighted images,and Hyper
MRI does not score over CT. Hypointense T1 weighted images,and Hyper
intense T2 images. It detects vascular encasement. MRCP is can image the
intense T2 images. It detects vascular encasement. MRCP is can image the
CBD and PD without
CBD and PD without cannulation
cannulation
CT SCAN
CT SCAN
Main role in malignant conditions
Main role in malignant conditions
mainly for localization of primary
mainly for localization of primary
tumors and mets
tumors and mets
•
• Best for Pancreatic
Best for Pancreatic
Carcinoma(Highly sensitive for
Carcinoma(Highly sensitive for
lesion >1mm)
lesion >1mm)
•
•Mainly done when ultrasound
Mainly done when ultrasound
fail or when there is ductal
fail or when there is ductal
dilation on ultrasound also to find
dilation on ultrasound also to find
level and cause of obstruction and
level and cause of obstruction and
in malignant conditions
in malignant conditions
MAGNETIC RESONANCE
MAGNETIC RESONANCE
CHOLANGIOPANCREATOGRAPHY (MRCP)
CHOLANGIOPANCREATOGRAPHY (MRCP)
•
• Noninvasive test to visualize
Noninvasive test to visualize
the hepatobiliary tree
the hepatobiliary tree
•
• Entire biliary tree and
Entire biliary tree and
pancreatic duct can be seen
pancreatic duct can be seen
•
• Best for Intra Hepatic stones
Best for Intra Hepatic stones
and CHOLEDOCHAL cysts
and CHOLEDOCHAL cysts
•
• SINGLE BEST FOR
SINGLE BEST FOR
CHOLANGIOCARCINOMA
CHOLANGIOCARCINOMA
•
• MRCP is better to determine
MRCP is better to determine
the extent and type of tumor as
the extent and type of tumor as
compared to ERCP
compared to ERCP
Endoscopic retrograde cholangiogram
Endoscopic retrograde cholangiogram
(ERCP)
(ERCP)
 Its an invasive
Its an invasive
procedure and has
procedure and has
therapeutic potential
therapeutic potential.
.
 Allows biopsy or brush
Allows biopsy or brush
cytology
cytology
 Stone extraction or
Stone extraction or
stenting It’s
stenting It’s
Endoscopic retrograde cholangiogram
Endoscopic retrograde cholangiogram
(ERCP)
(ERCP)

COMPLICATIONS
COMPLICATIONS
 Pancreatitis
Pancreatitis
Cholangitis
Cholangitis
Hemorrhage
Hemorrhage
Sepsis
Sepsis

 CONTRAINDICATIONS
CONTRAINDICATIONS
Unfav anatomy
Unfav anatomy
 Pseudocyst
Pseudocyst
Rec a/c pancreatitis
Rec a/c pancreatitis
ERCP vs MRCP
ERCP vs MRCP
 Routine ERCP may not be required if diagnosis is certain on CT scan
Routine ERCP may not be required if diagnosis is certain on CT scan
 ERCP can provide direct visualization of ampullary tumor and biopsy can be
ERCP can provide direct visualization of ampullary tumor and biopsy can be
taken
taken
 Preop biliary drainage is required as a therapeutic measure under following
Preop biliary drainage is required as a therapeutic measure under following
circumstances
circumstances
 Severe cholangitis
Severe cholangitis
 Patients whose surgery is delayed due to sepsis ,abnormal coaglation or
Patients whose surgery is delayed due to sepsis ,abnormal coaglation or
malnutrition
malnutrition
 a mode of palliation for obstructive jaundice.
a mode of palliation for obstructive jaundice.
 MRCP gives information about site of obstruction without injection of contrast
MRCP gives information about site of obstruction without injection of contrast
 No therapeutic potential, no tissue diagnosis is possible
No therapeutic potential, no tissue diagnosis is possible
Percutaneous
Percutaneous
Transhepatic
Transhepatic
Cholangiogram (PTC)
Cholangiogram (PTC)
•
• PTC is indicated when
PTC is indicated when
percutaneous intervention
percutaneous intervention
is needed and ERCP either
is needed and ERCP either
is inappropriate or has
is inappropriate or has
failed.
failed.
•
• Can be used to drain
Can be used to drain
biliary obstructions.
biliary obstructions.
Other Investigations
Other Investigations
 •
• Oral Cholecystography (OCG)>>>
Oral Cholecystography (OCG)>>> useful when patient has
useful when patient has
symptoms of cholelithiasis, but a negative ultrasound.
symptoms of cholelithiasis, but a negative ultrasound.
 •
• also is useful for counting the number of stones present.
also is useful for counting the number of stones present.
 •
• HIDA SCAN- useful in a/c cholecystitis
HIDA SCAN- useful in a/c cholecystitis,
,
 •
• DIAGNOSTIC LAPAROSCOPY-
DIAGNOSTIC LAPAROSCOPY-
 •
• ANGIOGRAPHY- abnormal vasc.anatomy
ANGIOGRAPHY- abnormal vasc.anatomy
 •
• Tumor markers- CA19-9 , CEA
Tumor markers- CA19-9 , CEA
Endoscopic Ultrasound
Endoscopic Ultrasound
 Much Superior to Conventional CT & comparable with
Much Superior to Conventional CT & comparable with
Latest Generation spiral CT
Latest Generation spiral CT
 Can differentiate small stone from tumor in periampullary
Can differentiate small stone from tumor in periampullary
region
region
 Biopsies are possible
Biopsies are possible
 Highly Operator dependent,costly
Highly Operator dependent,costly
 Echoendoscope is bigger hence uncomfortable for the
Echoendoscope is bigger hence uncomfortable for the
patient
patient
 It is mainly useful for pancreatic imaging and biopsies
It is mainly useful for pancreatic imaging and biopsies
assessment of nodal involvement & Vascular encasement
assessment of nodal involvement & Vascular encasement
 Prior to endoscopic treatment of pseudocysts.
Prior to endoscopic treatment of pseudocysts.
Biopsy not possible Biopsy Possible
Obstructive Jaundice etiology and management  the lect.ppt
Obstructive Jaundice etiology and management  the lect.ppt
Management of Obstructive
Management of Obstructive
Jaundice
Jaundice
Initial Evaluation: History
Initial Evaluation: History
 Jaundice, acholic stools, tea-colored urine
Jaundice, acholic stools, tea-colored urine
 Fever/chills, RUQ pain (cholangitis)
Fever/chills, RUQ pain (cholangitis)
 Could lead to life-threatening septic shock
Could lead to life-threatening septic shock
 Reasons to have hepatitis or cirrhosis?
Reasons to have hepatitis or cirrhosis?
 Alcohol, Viral, risk factors for viral hepatitis
Alcohol, Viral, risk factors for viral hepatitis
 Exposure to toxins or offending drugs
Exposure to toxins or offending drugs
 Inherited disorders or hemolytic conditions
Inherited disorders or hemolytic conditions
 Recent blood transfusions or blood loss?
Recent blood transfusions or blood loss?
 Is patient septic or on TPN?
Is patient septic or on TPN?
 Recent gallbladder surgery? (CBD injury)
Recent gallbladder surgery? (CBD injury)
Initial Evaluation: Physical Exam
Initial Evaluation: Physical Exam
 Signs of end stage liver disease (cirrhosis)
Signs of end stage liver disease (cirrhosis)
 Ascites, splenomegaly, spider angiomata, and
Ascites, splenomegaly, spider angiomata, and
gynecomastia
gynecomastia
 Jaundice evident first underneath the tongue,
Jaundice evident first underneath the tongue,
also evident in sclerae or skin
also evident in sclerae or skin
 Courvoisier’s sign = painless, but palpable or
Courvoisier’s sign = painless, but palpable or
distended gallbladder on exam
distended gallbladder on exam
 Could indicate
Could indicate malignant
malignant obstruction
obstruction
Perioperative management of obstructive
Perioperative management of obstructive
jaundice
jaundice
 •
• Preoperative biliary decompression improves postoperative morbidity
Preoperative biliary decompression improves postoperative morbidity
(usually causes increased hemorrhage & infections and is mainly Indicated in
(usually causes increased hemorrhage & infections and is mainly Indicated in
severe jaundice or when there are signs of impending liver failure. Endoscopic
severe jaundice or when there are signs of impending liver failure. Endoscopic
internal drainage is preferred over per-cutaneous external drainage
internal drainage is preferred over per-cutaneous external drainage
 •
• Intravenous administration of 5% dextrose saline followed by
Intravenous administration of 5% dextrose saline followed by
10%mannitol or loop diuretics to prevent renal failure(12 to 24 hours
10%mannitol or loop diuretics to prevent renal failure(12 to 24 hours
prior to surgery)
prior to surgery)
 •
• catheterization to monitor output
catheterization to monitor output
 •
• Broad spectrum antibiotic prophylaxis
Broad spectrum antibiotic prophylaxis
 •
• Parenteral vitamin K +/- fresh frozen plasma
Parenteral vitamin K +/- fresh frozen plasma
 •
• Need careful post-operative fluid balance to correct dehydration
Need careful post-operative fluid balance to correct dehydration
 •
• Correction of hypokalemia
Correction of hypokalemia
 •
• Cholestyramine and antihistamine for symptomatic relief of pruritis
Cholestyramine and antihistamine for symptomatic relief of pruritis
Summary of Treatment of
Summary of Treatment of
Obstructive Jaundice
Obstructive Jaundice
based on the cause
based on the cause
Treatment of Obstructive Jaundice is
Treatment of Obstructive Jaundice is
based on the cause
based on the cause
1) Cholelithiasis (gallstones
1) Cholelithiasis (gallstones)
)
Ideally ERCP followed by laparoscopic
Ideally ERCP followed by laparoscopic
Cholecystectomy Or open cholecystectomy with
Cholecystectomy Or open cholecystectomy with
CBD exploration
CBD exploration
2) Ca Head of Pancreas / Periampullary
2) Ca Head of Pancreas / Periampullary
Carcinoma/malignancy
Carcinoma/malignancy
of lower 3rd of CBD
of lower 3rd of CBD
a) Whipple resection
a) Whipple resection
(pancreaticoduodenectomy) is
(pancreaticoduodenectomy) is
mainly done which involves
mainly done which involves
removal of the
removal of the head & neck of
head & neck of
pancreas, duodenum, distal
pancreas, duodenum, distal
40% of the stomach, lower
40% of the stomach, lower
CBD, GB, upper 10 cm of
CBD, GB, upper 10 cm of
jejunum, regional L.Ns, and
jejunum, regional L.Ns, and
reconstruction through
reconstruction through
gastrojejunostomy,
gastrojejunostomy,
choledochojejunostmy and
choledochojejunostmy and
pancreaticojejunostomy
pancreaticojejunostomy
b) If not operable then we go for
Endoscopic sphincterotomy + stenting
with Percutaneous transhepatic biliary
drainage
3) Ca gall bladder
a) if involving cbd then Whipple resection is done
b) And in case of inoperable cases Endoscopic /
Radiological stenting is done
4) Choledochal cyst
 Surgical excision of the cyst with Reconstruction of the
extrahepatic biliary tree
 Biliary drainage is accomplished by Choledocho–
jejunostomy with a Roux – en – Y anastomosis
 Long-term follow-up is necessary because of
complications like cholangitis, lithiasis, anastomotic
stricture
5) Cholangiocarcinoma
5) Cholangiocarcinoma
Surgery depends on the stage of the tumor and may involve
Surgery depends on the stage of the tumor and may involve
Removal of the bile ducts
Removal of the bile ducts If the tumor is at a very early stage (Stage 1), just
If the tumor is at a very early stage (Stage 1), just
the bile ducts containing the cancer are removed. The remaining ducts in the
the bile ducts containing the cancer are removed. The remaining ducts in the
liver are then joined to the small bowel, allowing the bile to flow again.
liver are then joined to the small bowel, allowing the bile to flow again.
Partial liver resection
Partial liver resection If the tumor has begun to spread into the liver, the
If the tumor has begun to spread into the liver, the
affected part of the liver is removed, along with the bile ducts.
affected part of the liver is removed, along with the bile ducts.
Whipple procedure
Whipple procedure If the tumor is larger and has spread into nearby
If the tumor is larger and has spread into nearby
structures, the bile ducts, part of the stomach, part of the small bowel
structures, the bile ducts, part of the stomach, part of the small bowel
(duodenum), the pancreas, gall bladder, and the surrounding lymph nodes are
(duodenum), the pancreas, gall bladder, and the surrounding lymph nodes are
all removed
all removed
If surgery to remove the tumor is not possible
If surgery to remove the tumor is not possible, it may be possible to
, it may be possible to
relieve the blockage through stents through ERCP or PTC
relieve the blockage through stents through ERCP or PTC
6)Choledocholithiasis
6)Choledocholithiasis (stones in the CBD)
(stones in the CBD)
a)Treatment of choice is stone extraction through ERCP
a)Treatment of choice is stone extraction through ERCP
b)
b) Mechanical lithotripsy – through modified Dormia basket
Mechanical lithotripsy – through modified Dormia basket
c)Through shock waves laser technology
c)Through shock waves laser technology
d)Open exploration of the common bile duct is indicated in
d)Open exploration of the common bile duct is indicated in


Presence of multiple stones (more than 5) and Stones > 1 cm
Presence of multiple stones (more than 5) and Stones > 1 cm

Multiple intrahepatic stones
Multiple intrahepatic stones

Distal bile duct strictures
Distal bile duct strictures

Failure of ERCP
Failure of ERCP

Recurrence of CBD stones
Recurrence of CBD stones
7)Strictures are usually treated by endoscopic stenting
which is comparable to that of surgery, with similar
recurrence rates. Therefore, surgery should probably be
reserved for those patients with complete ductal obstruction
or for those in whom endoscopic therapy has failed. Surgery
with Roux-en-Y choledochojejunostomy or
hepaticojejunostomy is the standard of care with good or
excellent results in 80 to 90% of patients.
8) Stenosis of the Sphincter of Oddi endoscopic
or operative sphincterotomy will yield good results
Prognostic factors
Prognostic factors
( Pitt’s score)
( Pitt’s score)
Parameters
Parameters
Type of obstruction
Type of obstruction
(malignant or benign)
(malignant or benign)
Age > 60 yrs
Age > 60 yrs
S.Alb< 3gm/dl
S.Alb< 3gm/dl
S.Bil > 10mg%
S.Bil > 10mg%
S.Alk P > 100 IU
S.Alk P > 100 IU
S.Creatinine >1.3mg%
S.Creatinine >1.3mg%
TLC >10000/mm3
TLC >10000/mm3
Hematocrit <
Hematocrit < 30%
30%
Factors Mortality
Factors Mortality
Up to 2 0%
Up to 2 0%
3 4%
3 4%
4 7%
4 7%
5 44%
5 44%
6 67%
6 67%
8 100%
8 100%
Choledocholithiasis known before Surgery
Clear the common bile duct with an initial
Endoscopic papillotomy followed by
laparoscopic cholecystectomy.
Open Cholecystectomy with common bile duct
exploration.
Lap. Chole with Lap CBD Exploration
History & Pre-op. Investigations
Therapeutic Options
Choledocholithiasis Identified
during Cholecystectomy.
(1) Conversion to an open operation with
Common bile duct exploration,
(2) Laparoscopic common bile duct exploration,
(3) completion of the laparoscopic cholecystectomy
with postoperative endoscopic sphincterotomy
and stone extraction
Lap.U.S.
Cholangiogram
Transcystic
Choledochoscopy
Therapeutic Options
Choledocholithiasis Identified After
Cholecystectomy.
Theses patients are best managed with
endoscopic sphincterotomy and stone extraction.
If a T tube is still present from a recent common bile
duct exploration radiologic extraction of the stone
via the T tube tract is usually possible
Open Surgery is usually avoided
Therapeutic Options
Interventional Radiology
For retrieving the stone from
CBD by balloon Catheter
Imaging for Obstructive Jaundice
Imaging for Obstructive Jaundice
 RUQ Ultrasound
RUQ Ultrasound
 See stones, CBD diameter
See stones, CBD diameter
 CT scan
CT scan
 Identify both type & level of obstruction
Identify both type & level of obstruction
 ERCP
ERCP
 Direct visualization of biliary tree/panc ducts
Direct visualization of biliary tree/panc ducts
 Procedure of choice for choledocholithiasis
Procedure of choice for choledocholithiasis
 Diagnostic –AND- therapeutic (unlike MRCP)
Diagnostic –AND- therapeutic (unlike MRCP)
 PTC useul of obstruction is prox to CHD
PTC useul of obstruction is prox to CHD
 Endoscopic Ultrasound or EUS
Endoscopic Ultrasound or EUS
Extra-hepatic cholestasis:
Extra-hepatic cholestasis:
Pancreatic tumor
Pancreatic tumor -
- Tumor Detection
Tumor Detection
 Focal enlargement of the gland
Focal enlargement of the gland
 Hypodense mass on enhanced CT
Hypodense mass on enhanced CT
Secondary signs
Secondary signs:
:
 Mass effect or convex contour abnormality
Mass effect or convex contour abnormality
 Atrophic distal pancreatic parenchyma
Atrophic distal pancreatic parenchyma
 Dilatation of CBD and MPD in the absence of obstructive
Dilatation of CBD and MPD in the absence of obstructive
calculus (interupted duct sign)
calculus (interupted duct sign)
Extra-hepatic cholestasis:
Extra-hepatic cholestasis:
Ampulary tumor
Ampulary tumor
 Malignant epithelial tumor , ampula of vater
Malignant epithelial tumor , ampula of vater
 Presents with jaundice, weight loss. Abd or
Presents with jaundice, weight loss. Abd or
back pain
back pain
 Age: mean 65 yrs, no sex predeliction
Age: mean 65 yrs, no sex predeliction
 Prognosis: depends on nodeal status and
Prognosis: depends on nodeal status and
differentiation of tu, better than panc ca
differentiation of tu, better than panc ca
5 yrs- 38% if resected
5 yrs- 38% if resected
Treatment: Whipple if pos.
Treatment: Whipple if pos.
Extra-hepatic cholestasis:
Extra-hepatic cholestasis:
Ampulary tumor
Ampulary tumor
 Imaging:
Imaging:
 Lobulated soft tissue mass at ampula
Lobulated soft tissue mass at ampula
 “
“Double duct” sign
Double duct” sign
 CT: Hypodense mass , distention of du helpful
CT: Hypodense mass , distention of du helpful
Extra-hepatic cholestasis:
Extra-hepatic cholestasis:
Cholangiocarcinoma
Cholangiocarcinoma
 US: dilated BD, mass hyperechogenic(75%)
US: dilated BD, mass hyperechogenic(75%)
 CT: hypodense mass, IHBD dilatation, rim
CT: hypodense mass, IHBD dilatation, rim
enhancement with prog central patchy
enhancement with prog central patchy
enhancement, persistent enhancement on
enhancement, persistent enhancement on
delayed scan
delayed scan
Extra-hepatic cholestasis:
Extra-hepatic cholestasis:
Gallstone disease
 15%-20% of the population
15%-20% of the population
 Passage of gallstones through
Passage of gallstones through
biliary system causes ----->
biliary system causes ----->
 Biliary colic
Biliary colic
 Acute cholecystitis
Acute cholecystitis
 Choledocholithiasis
Choledocholithiasis
 Cholecystoenteric fistula
Cholecystoenteric fistula
Biliary stone disease - summary
Biliary stone disease - summary
 US is the modality of choice for demonstrating gallstones.
US is the modality of choice for demonstrating gallstones.
 US is the very good for demonstrating biliary ducts.
US is the very good for demonstrating biliary ducts.
 CT will show biliary ducts, less reliable for filling defects. Good
CT will show biliary ducts, less reliable for filling defects. Good
for neoplastic disease.
for neoplastic disease.
 MRCP is the non invasive study
MRCP is the non invasive study
 ERCP is invasive but potentially therapeutic.
ERCP is invasive but potentially therapeutic.
 PTC even more invasive, when ERCP is limited.
PTC even more invasive, when ERCP is limited.
Extra-hepatic cholestasis:
Extra-hepatic cholestasis: Cholelithiasis
Cholelithiasis
 Sensitivity 90%-95%
Sensitivity 90%-95%
 Variable SI
Variable SI
 Water/lipids contents
Water/lipids contents
 Elevated SI on T2 in
Elevated SI on T2 in
center (
center (
 50%)
50%)
Elevated SI on T1 (
Elevated SI on T1 (
 90%)
90%)
Co
Co, Fe, Mg
, Fe, Mg
(pigmented gallstones
(pigmented gallstones
[Ca
[Ca++
++
Bilirrubinate])
Bilirrubinate])
Ukaji M
Ukaji M et al.
et al. Eur J Radiol 2002 Jan;41(1):49-56
Eur J Radiol 2002 Jan;41(1):49-56
Obstructive Jaundice etiology and management  the lect.ppt
Obstructive Jaundice etiology and management  the lect.ppt
CT:Intrahepatic biliary dilatation
CT:Intrahepatic biliary dilatation
Obstructive Jaundice etiology and management  the lect.ppt
Obstructive Jaundice etiology and management  the lect.ppt
 Sphincteerotomy
Sphincteerotomy
ERCP :
ERCP :
Stone extraction
Stone extraction
Choledocholithiasis
Choledocholithiasis
 Asymptomatic
Asymptomatic
 Symptoms: calculi in distal CBD (90%)
Symptoms: calculi in distal CBD (90%)
 CBD stones
CBD stones
 15% pts. with gallstones
15% pts. with gallstones
 15% pts. with acute cholecystitis
15% pts. with acute cholecystitis
 Diagnosis pre laparoscopic cholecystectomy
Diagnosis pre laparoscopic cholecystectomy
 ERCP
ERCP
 Stones in only 27-50% of pts with clinical suspicion
Stones in only 27-50% of pts with clinical suspicion
Choledocholithiasis MR
Choledocholithiasis MR
 Normal CBD
Normal CBD
 98% of the pts
98% of the pts
 Foci of low SI surrounded by
Foci of low SI surrounded by
bright bile (T2-WI)
bright bile (T2-WI)
 Stones
Stones 
 2 mm
2 mm
 CBD stones
CBD stones
 Sensitivity 85-100%
Sensitivity 85-100%
 Specificity 90-99%
Specificity 90-99%
 Accuracy 89-97%
Accuracy 89-97%
 PPV 77-93%
PPV 77-93%
 NPV 94-100%
NPV 94-100%
Retrograde Cholangiogram - ERCP
Retrograde Cholangiogram - ERCP
Bile leak from the cystic duct after cholecystectomy
Courtesy of Michael Kimmey, M.D.
Primary sclerosing cholangitis (PSC) with stricture due to
cholangiocarcinoma. Courtesy of Robert L. Carithers, Jr., M.D.
Retrograde Cholangiogram - ERCP
Retrograde Cholangiogram - ERCP
Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis
Normal Extra hepatic BD
Narrowed abnormal
intra-heptic bile ducts.
Irregular dilation of intrahepatic and extrahepatic ducts.
Courtesy of Charles Rohrmann, M.D.
Retrograde Cholangiogram - ERCP
Retrograde Cholangiogram - ERCP
Biliary tree imaging modalities: ERCP,
Biliary tree imaging modalities: ERCP,
MRCP, PTC
MRCP, PTC
 MRCP –specific MR
MRCP –specific MR
sequence is employed
sequence is employed
to demonstrate the
to demonstrate the
biliary tree.
biliary tree.
 No IV contrast and
No IV contrast and
definitely no biliary
definitely no biliary
cannulation involved.
cannulation involved.
Magnetic Resonance Cholangio-
Magnetic Resonance Cholangio-
Pancreatography (MRCP)
Pancreatography (MRCP)
Two stones in the common bile duct
Two stones in the common bile duct
Courtesy of Udo Schmiedl, M.D.
Courtesy of Udo Schmiedl, M.D.
Biliary tree imaging modalities: ERCP,
Biliary tree imaging modalities: ERCP,
MRCP, PTC
MRCP, PTC
 PTC – direct
PTC – direct
cannulation of the
cannulation of the
biliary tree, and
biliary tree, and
iodinated contrast
iodinated contrast
injection.
injection.
 Advantageous over
Advantageous over
MRCP for showing
MRCP for showing
distal, small duct
distal, small duct
pathology and
pathology and
walls irregularity.
walls irregularity.
PTC
PTC
Percutaneous access to
Percutaneous access to
the biliary tree, through the
the biliary tree, through the
CBD, if possible, and into
CBD, if possible, and into
the duodenum.
the duodenum.
Downsides:
Downsides:
 External drainage
External drainage
 Procedural risks:
Procedural risks:
 Coagulopathy
Coagulopathy
 ascites
ascites
Obstructive Jaundice etiology and management  the lect.ppt
Obstructive Jaundice etiology and management  the lect.ppt
Treatment of Choledocholithiasis:
Treatment of Choledocholithiasis:
Preoperative Preparation:
Correct Clotting Dysfunction
Guard vs LCF
Guard vs RF
Definitive Treatment:
Remove Source of Obstruction (stone)
Remove Source of Stone (Gall bladder)
Reynold’s
Pentad
Obstructive Jaundice Charcot’s Triad
Chronic cholecystitis
Treatment
ttt
Of
Shock
3
rd
Generation
Cephalosporin
ERCP
Cholecystectomy
Carcinoma of head of pancreas
Symptoms Signs
Cachecxia
Criteria of obstructive jaundice
Pain which is common, characterized by starting as
vague (Lower abdomen or back)
Usually worsen in supine position & relived by lining
forward
It may be caused by
:
A) Tumor invasion of splanchnic plexuses
&
retroperitoneum
B) Obstruction of pancreatic duct
Digestive symptoms
Jaundice
Palpable liver
Palpable gall bladder
Tenderness
Ascites
Abdominal mass
In advanced cases
:
Nodular liver
Enlarged supraclavicular
lymph node
Periumblical adenopathy
Diagnosis & management of pancreatic cancer
:
It depends on results of
Spiral CT
1
)
Resectable: ask yourself if operative candidate or not
a)YES :Explore for resection
b) NO: =NONOPERATIVE: Palliation, Biliary stent &
Chemo/Radiotherapy
2
)
Unresectable: is it only Biliary or associated with
duodenal obstruction
a)only Biliary:Endobiliary stent
b)Both: Operative palliation(Biliary bypass)
Gastrojejunostomy
Celiac plexus block
Whipple operation:
Whipple operation:
Choledochoduodenostomy
Conclusion
Conclusion
•
• There are certain signs and symptoms common to all jaundiced patients (yellow
There are certain signs and symptoms common to all jaundiced patients (yellow
skin, itching).
skin, itching).
•
• Specific items from the history and physical examination along with blood work
Specific items from the history and physical examination along with blood work
can help the clinician classify jaundice into obstructive and nonobstructive
can help the clinician classify jaundice into obstructive and nonobstructive
jaundice.
jaundice.
•
• Surgical or other mechanical intervention almost exclusively is restricted to cases
Surgical or other mechanical intervention almost exclusively is restricted to cases
of obstructive (posthepatic) jaundice.
of obstructive (posthepatic) jaundice.
•
• Imaging evaluation of the gallbladder and biliary system plays an important role
Imaging evaluation of the gallbladder and biliary system plays an important role
in the evaluation of obstructive jaundice by locating the site and disclosing the
in the evaluation of obstructive jaundice by locating the site and disclosing the
nature of the obstruction.
nature of the obstruction.
•
• Ultrasound imaging usually is the first step for suspected biliary stone disease.
Ultrasound imaging usually is the first step for suspected biliary stone disease.
•
• The physician’s level of suspicion about benign versus malignant causes of
The physician’s level of suspicion about benign versus malignant causes of
obstructive jaundice will lead to different radiologic tests and interventions.
obstructive jaundice will lead to different radiologic tests and interventions.
•
• Treatment is tailored to the cause of obstruction
Treatment is tailored to the cause of obstruction.
.
THAK YOU
THAK YOU

More Related Content

PPT
Jaundice
PPTX
Jaundice
PPTX
jaundice.pptx...........................
PPTX
Jaundice
PDF
jaundice presentation portable display format pdf.pdf
PPTX
Approach to a case of Jaundice.pptx
PPTX
JAUNDICE PRESENTATION FOR MEDICAL STUDENTS AROUND THE WORLD
PPTX
Jaundice – a detailed view by Rxvichu :) :)
Jaundice
Jaundice
jaundice.pptx...........................
Jaundice
jaundice presentation portable display format pdf.pdf
Approach to a case of Jaundice.pptx
JAUNDICE PRESENTATION FOR MEDICAL STUDENTS AROUND THE WORLD
Jaundice – a detailed view by Rxvichu :) :)

Similar to Obstructive Jaundice etiology and management the lect.ppt (20)

PDF
jaundice.pdf
PPTX
clinicalapproachtojaundice-140123123013-phpapp01.pptx
PPTX
JAUNDICE.pptx
PPTX
JAUNDICE.pptx
PPTX
Bilirubin Metabolism Presentation Yr 2 CHOs 2023 - Copy.pptx
PPTX
Jaundice general survey
PPTX
Liver function test and jaundice
PPT
Jaundice (new).ppt
PPTX
Jaundice & cholestatic liver diseases
PPTX
Approach to jaundice
PPTX
PATHOPHYSIOLOGY OF JAUNDICE AND ITS TYPES.pptx
PPTX
All about Jaundice
PPTX
Approach to jaundice
PPT
JAUNDICE-.ppt_Biochemistry for nursing students
PPTX
Jaundice clinical approach Dr Mokhtar.pptx
PPTX
HEME DEGRADATION and Jaundice Powerpoint presentation
PPTX
jaundice approach
PPT
jaundice - yellow discoloration of tissue.
PPTX
Jaundice.pptx
PPTX
clinical approch to jaundice.pptx........
jaundice.pdf
clinicalapproachtojaundice-140123123013-phpapp01.pptx
JAUNDICE.pptx
JAUNDICE.pptx
Bilirubin Metabolism Presentation Yr 2 CHOs 2023 - Copy.pptx
Jaundice general survey
Liver function test and jaundice
Jaundice (new).ppt
Jaundice & cholestatic liver diseases
Approach to jaundice
PATHOPHYSIOLOGY OF JAUNDICE AND ITS TYPES.pptx
All about Jaundice
Approach to jaundice
JAUNDICE-.ppt_Biochemistry for nursing students
Jaundice clinical approach Dr Mokhtar.pptx
HEME DEGRADATION and Jaundice Powerpoint presentation
jaundice approach
jaundice - yellow discoloration of tissue.
Jaundice.pptx
clinical approch to jaundice.pptx........
Ad

More from HamedRashad3 (19)

PPT
Open surgical Adrenalectomy for adrenal tumors the lect.ppt
PPT
Adrenal Incidentaloma etiology and man the lect.ppt
PPT
Primary Sclerosing Cholangitis management the lect .ppt
PPT
Choledochal cyst the lect. types and management
PPT
Cholangiocarcinoma diagnosis and management the lect.ppt
PPT
Common BD stones etiology and management the lect.ppt
PPT
Acute abdomen Etiology and Management the lect .ppt
PPT
Retroperitoneal Hematoma causes and management the lect.ppt
PPT
Diaphragmatic rupture & injuries how to repair the lect.ppt
PPT
Damage control and its importance the lect.ppt
PPT
Trauma special abdominal injuries lecture.ppt
PPT
Trauma primary and secondary survay abdo and thoracic injuries lecture -.ppt
PPT
Hollow Viscus Injuries diagnosis & treatment
PPT
Principle of abdom trauma the lect main.ppt
PPT
Acute abdomen medical and surgical the lect .ppt
PPT
Total Open Thyroidectomy Techniqueslecture.ppt
PPT
Types and technique of Thyroidectomy lecture.ppt
PPT
Detailed technique of Thyroidectomy .ppt
PPT
Management of Pheochromocytoma the lect.ppt
Open surgical Adrenalectomy for adrenal tumors the lect.ppt
Adrenal Incidentaloma etiology and man the lect.ppt
Primary Sclerosing Cholangitis management the lect .ppt
Choledochal cyst the lect. types and management
Cholangiocarcinoma diagnosis and management the lect.ppt
Common BD stones etiology and management the lect.ppt
Acute abdomen Etiology and Management the lect .ppt
Retroperitoneal Hematoma causes and management the lect.ppt
Diaphragmatic rupture & injuries how to repair the lect.ppt
Damage control and its importance the lect.ppt
Trauma special abdominal injuries lecture.ppt
Trauma primary and secondary survay abdo and thoracic injuries lecture -.ppt
Hollow Viscus Injuries diagnosis & treatment
Principle of abdom trauma the lect main.ppt
Acute abdomen medical and surgical the lect .ppt
Total Open Thyroidectomy Techniqueslecture.ppt
Types and technique of Thyroidectomy lecture.ppt
Detailed technique of Thyroidectomy .ppt
Management of Pheochromocytoma the lect.ppt
Ad

Recently uploaded (20)

PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
Introduction to Medical Microbiology for 400L Medical Students
PPT
Dermatology for member of royalcollege.ppt
PPTX
thio and propofol mechanism and uses.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
PPTX
Physiology of Thyroid Hormones.pptx
PPT
Opthalmology presentation MRCP preparation.ppt
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PDF
Nursing manual for conscious sedation.pdf
PPT
Infections Member of Royal College of Physicians.ppt
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
y4d nutrition and diet in pregnancy and postpartum
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PPTX
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
PPTX
Antepartum_Haemorrhage_Guidelines_2024.pptx
preoerative assessment in anesthesia and critical care medicine
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Introduction to Medical Microbiology for 400L Medical Students
Dermatology for member of royalcollege.ppt
thio and propofol mechanism and uses.pptx
Reading between the Rings: Imaging in Brain Infections
Forensic Psychology and Its Impact on the Legal System.pdf
Physiology of Thyroid Hormones.pptx
Opthalmology presentation MRCP preparation.ppt
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Nursing manual for conscious sedation.pdf
Infections Member of Royal College of Physicians.ppt
nephrology MRCP - Member of Royal College of Physicians ppt
OSCE Series ( Questions & Answers ) - Set 6.pdf
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
y4d nutrition and diet in pregnancy and postpartum
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
Antepartum_Haemorrhage_Guidelines_2024.pptx

Obstructive Jaundice etiology and management the lect.ppt

  • 3. Anatomy of biliary system Anatomy of biliary system
  • 4. JAUNDICE It is yellowish discoloration of Skin, mucous membranes, sclera Due to excess plasma bilirubin Is not a disease but rather a sign that can occur in many different diseases Normal range 5-17 m mol/l Clinically obvious 50 mmol/l (2.5mg/dl) The differential diagnosis for yellowing of the skin is limited. In addition to jaundice, it includes Carotenoderma The use of the drug Quinacrine Excessive exposure to phenols in carotenoderma the pigment is concentrated on the palms, soles, forehead, and nasolabial folds. Carotenoderma can be distinguished from jaundice by the sparing of the sclerae
  • 5. Bilirubin Production & Metabolism: Bilirubin Production & Metabolism: Formation of Bilirubin Mainly in RES (Spleen) Conjugation of bilirubin in Hepatocyte About 70 to 80% of the 250 to 300 mg of bilirubin produced each day is derived from the breakdown of hemoglobin in senescent red blood cells The remainder comes from prematurely destroyed erythroid cells in bone marrow and from the turnover of hemoproteins such as myoglobin and cytochromes found in tissues throughout the body. Excretion
  • 6. E V Pathway for RBC Scavenging E V Pathway for RBC Scavenging Liver, Spleen & Bone marrow Hemoglobin Globin Amino acids Amino acid pool Heme Bilirubin Fe2+ Excreted Phagocytosis & Lysis Through Liver 6 www.drsarma.in
  • 7. BILE SALTS BILE SALTS These are synthesized by the hepatic cells. Cholic acid These are synthesized by the hepatic cells. Cholic acid is formed from cholesterol and is conjugated with is formed from cholesterol and is conjugated with either taurine or glycine to form the bile salts – either taurine or glycine to form the bile salts – glcyocholic and taurocholic acids.At the pH of bile glcyocholic and taurocholic acids.At the pH of bile 7.3-7.7 taurocholate and glycocholate exist as anions. 7.3-7.7 taurocholate and glycocholate exist as anions. They are water soluble and are necessary for the They are water soluble and are necessary for the digestion of fats. digestion of fats. In obstructive jaundice they are regurgitated into blood In obstructive jaundice they are regurgitated into blood and are filtered by the kidneys and so are present in and are filtered by the kidneys and so are present in urine urine I I
  • 8. Van den Burgh Test Van den Burgh Test  When a mixture of sulphanilic acid, HCl, and sodium When a mixture of sulphanilic acid, HCl, and sodium nitrite is added to sierum containing an excess of nitrite is added to sierum containing an excess of bilirubin glucuronide a reddish violet colour results max bilirubin glucuronide a reddish violet colour results max in 30secs. This is called the Direct reaction in 30secs. This is called the Direct reaction  When the reagents are mixed with serum containing an When the reagents are mixed with serum containing an excess of bilirubin no colour develops until alcohol is excess of bilirubin no colour develops until alcohol is added whereupon the reddish-violet colour appears. added whereupon the reddish-violet colour appears.
  • 9. DEFINITION DEFINITION  Yellow discolouration of body tissues Yellow discolouration of body tissues  excess circulating bilirubin excess circulating bilirubin  Normal bilirubin Normal bilirubin 0.2-1.2mg%(5-17umol/l) 0.2-1.2mg%(5-17umol/l) Jaundice Jaundice   2-3mg% or (>40umol/l) 2-3mg% or (>40umol/l) S.cl.jaun. S.cl.jaun.   1-2mg% 1-2mg%  Best observed Best observed  sites cont. elast. Tissues sites cont. elast. Tissues eg.: sclera, skin, mm eg.: sclera, skin, mm
  • 11. CLASSIFICATION CLASSIFICATION  No satisfactory classification No satisfactory classification  Classically: Classically: Prehepatic (excess dest., hlytic) Prehepatic (excess dest., hlytic) Hepatic (liver damage) Hepatic (liver damage) Post hepatic (obst. Or surgical) Post hepatic (obst. Or surgical) (stasis without a lesion requiring surg.. (stasis without a lesion requiring surg..  Conj. Or Unconj.: Conj. Or Unconj.: little cl. Value (often mixed) little cl. Value (often mixed)  D D  Surgical or Non-surgical Surgical or Non-surgical
  • 12. CLASSIFICATION CLASSIFICATION  Old standard classification Old standard classification : : pre prehepatic hepatic (hemolytic) (hemolytic) , , hepatic hepatic (hepatocellular )& (hepatocellular )& post posthepatic hepatic (obstructive ) (obstructive )  New classification New classification : : cholestatic cholestatic (inrta & extra hepatic cholestasis) (inrta & extra hepatic cholestasis) VS VS non-cholestatic non-cholestatic (hepatocellular insufficiency) (hepatocellular insufficiency)
  • 13. Jaundice – Classification Jaundice – Classification  Normal Serum Bilirubin (SB) is 0.3 to 1.0 mg% Normal Serum Bilirubin (SB) is 0.3 to 1.0 mg%  Jaundice is increased levels of SB > 1.0 mg% Jaundice is increased levels of SB > 1.0 mg%  Over production of Bilirubin (Hemolytic) Over production of Bilirubin (Hemolytic)  From hemolysis of RBC From hemolysis of RBC  Lysis of RBC precursors – Ineffective erythropoesis Lysis of RBC precursors – Ineffective erythropoesis  Impaired hepatic function (Hepatitic) Impaired hepatic function (Hepatitic)  Hepatocellular dysfunction in handling bilirubin Hepatocellular dysfunction in handling bilirubin  Uptake, Metabolism and Excretion of bilirubin Uptake, Metabolism and Excretion of bilirubin  Obstruction to bile flow (Obstructive) Obstruction to bile flow (Obstructive)  Intrahepatic cholestasis Intrahepatic cholestasis  Extrahepatic Obstruction (Surgical Jaundice Extrahepatic Obstruction (Surgical Jaundice) ) 13 www.drsarma.in
  • 14. Etiology Of Jaundice: Etiology Of Jaundice: Increase of production Impaired of Clearance
  • 15. Pre-Hepatic Pre-Hepatic  Haemolytic anaemia – hereditary spherocytosis, Haemolytic anaemia – hereditary spherocytosis, sickle cell, thalassaemia, Gilbert’s syndrome sickle cell, thalassaemia, Gilbert’s syndrome  High levels of unconjugated bilirubin, normal High levels of unconjugated bilirubin, normal LFTs, raised reticulocytes LFTs, raised reticulocytes  Investigate further with blood film and Investigate further with blood film and autoantibody screen autoantibody screen
  • 16. Hepatic Hepatic  Hepatic injury – viral hepatitis, sclerosis, Hepatic injury – viral hepatitis, sclerosis, cirrhosis, poisons, drugs cirrhosis, poisons, drugs  Bilirubin tends to be conjugated, (jaundice Bilirubin tends to be conjugated, (jaundice occurs out of failure to excrete, not conjugate) occurs out of failure to excrete, not conjugate)  Abnormal LFTs (raised ALT/AST) Abnormal LFTs (raised ALT/AST)  Investigate further with viral titres, USS, liver Investigate further with viral titres, USS, liver biopsy biopsy
  • 17. Post-Hepatic (Your Turn) Post-Hepatic (Your Turn) Wall Lumen Outside Lumen Sclerosing cholangitis Gallstones Tumour (pancreatic, ampullary, duodenal) Benign stricture Schistosomiasis Chronic pancreatitis Cholangiocarcinoma Clonorchis Portal lymphadenopathy •Raised conjugated bilirubin (absorbed from biliary tree) •Decreased urinary urobilinogen (bilirubin does not make it to the small bowel) •Obstructed LFTs (raised ALP and GGT) •Further investigation with USS, and then ERCP/CT as appropriate
  • 18. Lab Diagnosis of Jaundice – D.D Lab Diagnosis of Jaundice – D.D 18 Features Prehepatic (Heamolytic) Intrahepatic (Hepatocellular) Posthepatic (Obstructive) Unconjugated ↑ Normal Normal Conjugated Normal ↑ ↑ AST or ALT Normal ↑ ↑ Normal Alkaline phos. and GGT Normal Normal ↑ ↑ Urine bilirubin Absent Present Increased Urobilinogen Increased Present Absent www.drsarma.in
  • 20. Definition Definition  Jaundice is the yellowish pigmentation of the skin, the Jaundice is the yellowish pigmentation of the skin, the conjunctival membranes over the sclerae, and other mucous conjunctival membranes over the sclerae, and other mucous membranes caused by hyperbilirubinemia. membranes caused by hyperbilirubinemia.  Total serum bilirubin values are normally 0.2-1.2 mg/dL. Total serum bilirubin values are normally 0.2-1.2 mg/dL. Jaundice may not be clinically recognizable until levels are at Jaundice may not be clinically recognizable until levels are at least 3 mg/dL. least 3 mg/dL.  Jaundice is not a diagnosis. Jaundice is not a diagnosis.  Surgical jaundice is any jaundice amenable to surgical treatment. Surgical jaundice is any jaundice amenable to surgical treatment. The majority are due to extrahepatic biliary obstruction. The majority are due to extrahepatic biliary obstruction.  Not all obstructive jaundice is surgical jaundice e.g hepatitis and Not all obstructive jaundice is surgical jaundice e.g hepatitis and not all surgical jaundice is due to not all surgical jaundice is due to obstruction e.g congenital obstruction e.g congenital spherocytosis spherocytosis
  • 21. Epidemiology Epidemiology RACE RACE • • The racial predilection depends on the cause of the biliary The racial predilection depends on the cause of the biliary obstruction. obstruction. • • Gallstones are the most common cause of biliary obstruction. Gallstones are the most common cause of biliary obstruction. • • Persons of Hispanic origin and Northern Europeans have a Persons of Hispanic origin and Northern Europeans have a higher risk of gallstones compared to people from Asia and higher risk of gallstones compared to people from Asia and Africa. Africa. • • Native Americans (particularly Pima Indians)have a lifetime Native Americans (particularly Pima Indians)have a lifetime chance of developing gallstones as high as 80%. chance of developing gallstones as high as 80%.
  • 22. Epidemiology Epidemiology SEX SEX • • Women are much more likely to develop gallstones than men. Women are much more likely to develop gallstones than men. • • This increased risk is likely caused by the effect of estrogen on This increased risk is likely caused by the effect of estrogen on the liver, causing it to remove more cholesterol from the blood the liver, causing it to remove more cholesterol from the blood and diverting it into the bile. and diverting it into the bile.
  • 23. Pathophysiolog Pathophysiology y  To better understand these disorders, a brief discussion of the normal To better understand these disorders, a brief discussion of the normal structure and function of the biliary tree is needed. structure and function of the biliary tree is needed.  Bile is the exocrine secretion of the liver and is produced continuously by Bile is the exocrine secretion of the liver and is produced continuously by hepatocytes. It contains cholesterol and waste products, such as bilirubin hepatocytes. It contains cholesterol and waste products, such as bilirubin and bile salts, which aid in the digestion of fats. Half the bile produced and bile salts, which aid in the digestion of fats. Half the bile produced runs directly from the liver into the duodenum via a system of ducts, runs directly from the liver into the duodenum via a system of ducts, ultimately draining into the common bile duct (CBD). The remaining 50% ultimately draining into the common bile duct (CBD). The remaining 50% is stored in the gallbladder. is stored in the gallbladder.  In response to a meal, this bile is released from the gallbladder via the In response to a meal, this bile is released from the gallbladder via the cystic duct, which joins the hepatic ducts from the liver to form the CBD. cystic duct, which joins the hepatic ducts from the liver to form the CBD. The CBD courses through the head of the pancreas for approximately 2 cm The CBD courses through the head of the pancreas for approximately 2 cm before passing through the ampulla of Vater into the duodenum before passing through the ampulla of Vater into the duodenum
  • 25. Causes Causes  Causes of biliary obstruction can be separated into Causes of biliary obstruction can be separated into intrahepatic and extrahepatic. intrahepatic and extrahepatic.  intrahepatic causes are most commonly hepatitis and intrahepatic causes are most commonly hepatitis and cirrhosis, Drugs e.g thiazides, chlorpromazine, cirrhosis, Drugs e.g thiazides, chlorpromazine, augmentin, etc augmentin, etc  Extrahepatic causes may be further subdivided into Extrahepatic causes may be further subdivided into intrinsic, intraluminal, and extrinsic intrinsic, intraluminal, and extrinsic
  • 27. Obstruction of common bile duct leading to pain & jaundice May Complicate to Charcot’s Triad: 1-Pain 2-Jaundice 3-Fever Reynold’s Pentad: 1-Pain 2-Jaundice 3-Fever 4-Altered Mental State 5-Shock Abdominal Ex: 1-Gall Bladder: in 80%Not Distended When gall bladder be distended?? Murphy’s sign +ve 2-Liver:Enlarged?????
  • 28. Incidence According to large study Incidence According to large study
  • 29. Causes of Cholestatic Jaundice Causes of Cholestatic Jaundice 29 Intrahepatic Intrahepatic Extrahepatic Extrahepatic Acute liver injury, Viral hepatitis Acute liver injury, Viral hepatitis Choledocholithiasis Choledocholithiasis Alcohol hepatitis, Drugs Alcohol hepatitis, Drugs Stone obstructing CBD, CD Stone obstructing CBD, CD Chronic liver injury, PBC, PSC Chronic liver injury, PBC, PSC Biliary strictures Biliary strictures Autoimmune cholangiopathy Autoimmune cholangiopathy Cholangiocarcinoma Cholangiocarcinoma Drugs, Total parenteral nutrition Drugs, Total parenteral nutrition Pancreatic carcinoma Pancreatic carcinoma Systemic infection, Postoperative Systemic infection, Postoperative Pancreatitis, Periampullary Ca Pancreatitis, Periampullary Ca Benign causes, Amyloid, lymphoma Benign causes, Amyloid, lymphoma PSC, Biliary atresia, duct cysts PSC, Biliary atresia, duct cysts www.drsarma.in
  • 30. Aetiology of obstructive jaundice Aetiology of obstructive jaundice Common Common  Common bile duct stones  Carcinoma of the head of pancreas  Malignant porta hepatis lymph nodes  Ampullary carcinoma  Pancreatitis ,pseudocysts  Benign strictures  Iatrogenic, trauma  Recurrent cholangitis  Mirrizi's syndrome  Sclerosing cholangitis  Cholangiocarcinoma  Biliary atresia  Choledochal cysts
  • 31. Drugs causing Cholestasis Drugs causing Cholestasis www.drsarma.in 31  Anabolic steroids (testosterone, norethandrolone) Anabolic steroids (testosterone, norethandrolone)  Antithyroid agents (methimazole) Antithyroid agents (methimazole)  Azathioprine (Immunosuppressive drug) Azathioprine (Immunosuppressive drug)  Chlorpromazine HCI (Largactil) Chlorpromazine HCI (Largactil)  Clofibrate, Erythromycin estolate Clofibrate, Erythromycin estolate  Oral contraceptives (containing estrogens) Oral contraceptives (containing estrogens)  Oral hypoglycemics (especially chlorpropamide) Oral hypoglycemics (especially chlorpropamide)
  • 32. DDx: Conjugated Bilirubinemia DDx: Conjugated Bilirubinemia  Intrahepatic cholestasis/impaired excretion Intrahepatic cholestasis/impaired excretion  Hepatitis (viral, alcoholic, and non-alcoholic) Hepatitis (viral, alcoholic, and non-alcoholic)  Any cause of hepatocellular injury Any cause of hepatocellular injury  Primary biliary cirrhosis or end-stage liver dz Primary biliary cirrhosis or end-stage liver dz  Sepsis and hypoperfusion states Sepsis and hypoperfusion states  TPN TPN  Pregnancy Pregnancy  Infiltrative dz: TB, amyloid, sarcoid, lymphoma Infiltrative dz: TB, amyloid, sarcoid, lymphoma  Drugs/toxins i.e. chlorpromazine, arsenic Drugs/toxins i.e. chlorpromazine, arsenic  Post-op patient or post-organ transplantation Post-op patient or post-organ transplantation  Hepatic crisis in sickle cell disease Hepatic crisis in sickle cell disease
  • 33. DDx: Obstructive Jaundice DDx: Obstructive Jaundice Obstructive Jaundice– extrahepatic cholestasis Obstructive Jaundice– extrahepatic cholestasis  Choledocholithiasis Choledocholithiasis (CBD or CHD stone) (CBD or CHD stone)  Cancer Cancer (peri-ampullary or cholangioCA) (peri-ampullary or cholangioCA)  Strictures Strictures after invasive procedures after invasive procedures  Acute and chronic Acute and chronic pancreatitis pancreatitis  Primary sclerosing cholangitis (PSC) Primary sclerosing cholangitis (PSC)  Parasitic infections Parasitic infections  Ascaris lumbricoides, liver flukes Ascaris lumbricoides, liver flukes Just remember top 5 (not parasites) Just remember top 5 (not parasites)
  • 34. Common causes Common causes  Gallstones and carcinoma of pancreas Gallstones and carcinoma of pancreas  Rare cholangiocarcinoma, pancreatitis Rare cholangiocarcinoma, pancreatitis  USS > 90% gallstones USS > 90% gallstones  No gallstones or significant pain – CT No gallstones or significant pain – CT  Avoid knee-jerk ERCP Avoid knee-jerk ERCP  Serial LFTs vital – fluctuant or progressive Serial LFTs vital – fluctuant or progressive  GS in GB but history equivocal - MRCP GS in GB but history equivocal - MRCP
  • 35. Haemolytic Hepatocellular Obstructive Long standing Constitutional symptoms Progressive Low bilirubin levels Blood transfusion High bilirubin levels Anaemia Epidemic Pruritus hepatosplenomegaly Exposure to toxins Wt. loss/malena Ulcerations over legs Septicemia Abdominal lump Splenomegaly Colour of stools Previous biliary surgery
  • 37. Clinical Picture & Diagnosis Clinical Picture & Diagnosis Diagnosis established by the triad: Diagnosis established by the triad: HISTORY HISTORY EXAMINATION EXAMINATION INVESTIGATIONS INVESTIGATIONS
  • 38. History of presenting illness History of presenting illness  • • Gradually progressive jaundice Gradually progressive jaundice  • • Recurrent episodes of itching Recurrent episodes of itching  • • White stools for the last 2 months White stools for the last 2 months  • • Dark yellow urine Dark yellow urine  • • Generalized weakness & fatigability- 6 Generalized weakness & fatigability- 6 months months  • • Weight loss in the last 1 year Weight loss in the last 1 year  • • Reduced appetite Reduced appetite  • • No fever No fever
  • 39. H/o past illness • No h/o DM, HT, TB, Chest pain • No previous surgery(no history of cholelithiasis) Personal History • Decreased appetite with pale stools • Normal bladder habits but deep yellowish • Smoker – 25 yrs • Non-alcoholic
  • 40. General Physical Examination General Physical Examination – – Pulse 88/min, BP 110/70 Pulse 88/min, BP 110/70 – – anemia +, Jaundice ++ anemia +, Jaundice ++ – – No Lymphadenopathy No Lymphadenopathy – – Scratch marks Scratch marks Per abdomen Per abdomen – – Soft non-tender Soft non-tender – – Gall bladder palpable Gall bladder palpable – – No free fluid No free fluid
  • 41. Clinical Picture & Diagnosis Clinical Picture & Diagnosis  A. HISTORY: A. HISTORY: Age, sex, parity, habits Age, sex, parity, habits Occupation Occupation  sheep farmer sheep farmer hydatid hydatid Fam.hist. Fam.hist.  anae.,stones,splenect.(her.sph.) anae.,stones,splenect.(her.sph.) Pers.Hist.:Histort of bil.surg. Pers.Hist.:Histort of bil.surg. stricture/resid.stone stricture/resid.stone alcohol alcohol  cirrhosis, chr. Pancreatitis. cirrhosis, chr. Pancreatitis. drugs drugs chloropromazine hlysis/stasis chloropromazine hlysis/stasis
  • 42. Clinical Picture & Diagnosis Clinical Picture & Diagnosis Symptoms: Symptoms: -Jaundice: -Jaundice: sudden sudden:=stones, :=stones, grad grad=cirrho,,panc ca, =cirrho,,panc ca, progressive progressive=malignant i =malignant intermittent ntermittent=stone,ca amp. =stone,ca amp. -Pain: -Pain:painless painless -Fever & chills: -Fever & chills: stasis & infection stasis & infection -Pruritis: -Pruritis: bile salt irrit. Of cut nerves bile salt irrit. Of cut nerves -Wt. loss: -Wt. loss: malig. / chr. Hep-cellular. malig. / chr. Hep-cellular.
  • 44. Clinical Picture & Diagnosis Clinical Picture & Diagnosis  B.EXAMINATION(signs) B.EXAMINATION(signs) / / General Local General Local   Depth of J Depth of J. .  Lem. yellow=hlyt ,orange=Hep.cell deep= Lem. yellow=hlyt ,orange=Hep.cell deep= obst. obst. Anaemia Anaemia  malig./cirrhosis/ hlytic malig./cirrhosis/ hlytic L failure L failure palm erythema, spid. nevi,foetor hep palm erythema, spid. nevi,foetor hep gynecom., test atrophy, clubbing, flapping trermor gynecom., test atrophy, clubbing, flapping trermor Supra. LN Supra. LN metas. metas. Skin Skin scratches scratches Fever Fever itis,sept. itis,sept.
  • 45. Clinical Picture & Diagnosis Clinical Picture & Diagnosis Local signs: Local signs: Scar Scar  previous surg previous surg. Caput med. . Caput med. PHT PHT Site of tend.(Murphy’s) GB Site of tend.(Murphy’s) GB   Liver Liver   Hard nod= 2ries , small nod= Hard nod= 2ries , small nod= cirrhosis,smooth=cholestasis,tender=hitits cirrhosis,smooth=cholestasis,tender=hitits  Spleen Spleen   cong hlytic an, PHT cong hlytic an, PHT MASS MASS  hard irreg hard irreg. Ascites . Ascites  malig & liver malig & liver PR PR colour ,1ry, deposits. colour ,1ry, deposits.
  • 46. Investigations Investigations  C. INVESTIGATIONS C. INVESTIGATIONS: : Aim Aim   define aetiology, assess cond., define aetiology, assess cond., proper ttt. proper ttt. LABORATORY LABORATORY IMAGING IMAGING ENDOSCOPIC ENDOSCOPIC HISTOPATH. HISTOPATH. SPECIFIC SPECIFIC
  • 47. Laboratory: Laboratory: LABORATORY: LABORATORY: 1 1. . CBC CBC: :  WBC= cholangitis, anaem=Malig. WBC= cholangitis, anaem=Malig. spherocytosis, RC fragility, reticulocytes spherocytosis, RC fragility, reticulocytes glucose tol. Curve glucose tol. Curve   dist in panc ca. dist in panc ca. urine urine  liquorice, liquorice,  bilirubin in ob, bile salts, bilirubin in ob, bile salts, no urobilinogen no urobilinogen stool stool: clay colour, no or : clay colour, no or  stercobilin, stercobilin,  fat, occult bld=malig. fat, occult bld=malig.
  • 48. Laboratory Laboratory  2.Liver Function tests: 2.Liver Function tests:   Serum bilirubin Serum bilirubin   total & direct> 20% total & direct> 20%  Alk. Phosph. Alk. Phosph.   35 KAU= calc ./ 50KAU= malig 35 KAU= calc ./ 50KAU= malig  Proth act. Proth act.   Cholestatic & H cellular Cholestatic & H cellular correctable by vit K correctable by vit K  ALT & ALA enz ALT & ALA enz 5 nucleotidase & 5 nucleotidase &  -GT -GT
  • 49. Laboratory Laboratory  3. Serum amylase: 3. Serum amylase: N N   calc., calc.,  pancitis. &malig. pancitis. &malig. 4. Tumours markers: 4. Tumours markers: +ve in malig. +ve in malig.  CA 19.9, CEA, panc. CA 19.9, CEA, panc. oncofoetal antigen oncofoetal antigen
  • 50. IMAGING & ENDOSCOPY IMAGING & ENDOSCOPY -ULTRA SOUND -ULTRA SOUND -CT & MRI -CT & MRI -Ba meal -Ba meal -CHOLANGIOGRAPHY -CHOLANGIOGRAPHY ERCP/PTC/MRCP ERCP/PTC/MRCP - D. LAPAROSCOPY - D. LAPAROSCOPY
  • 51. Plain x-ray abdomen Plain x-ray abdomen
  • 52. IMAGING & ENDOSCOPY IMAGING & ENDOSCOPY - -ULTRASOUND ULTRASOUND: : 1 or X stones, intra or extra hep bil.dil 1 or X stones, intra or extra hep bil.dil CBD caliber & thickness CBD caliber & thickness ( (>10mmw contrast or >7mm wout) >10mmw contrast or >7mm wout)  panc. Head/ T at porta hep./Ascites/liver panc. Head/ T at porta hep./Ascites/liver - -CT & MRI CT & MRI: : panc & retroperit. panc & retroperit. - -Ba meal Ba meal ( (hypot.duod) hypot.duod) wide D curve & inv 3 of ca amp wide D curve & inv 3 of ca amp
  • 54. IMAGING & ENDOSCOPY IMAGING & ENDOSCOPY  CHOLANGIOGRAPHY: CHOLANGIOGRAPHY: ERCP ERCP  low CBD low CBD advantage: advantage: D visualise bili passage & panc d D visualise bili passage & panc d (db (db duct sign) duct sign) detect any path. detect any path. cytology cytology ttt sphincterotomy, stone extra, ttt sphincterotomy, stone extra, NB drainage, stenting NB drainage, stenting comps: pitis, perforation, bleeding comps: pitis, perforation, bleeding
  • 57. IMAGING & ENDOSCOPY IMAGING & ENDOSCOPY  PTC: PTC: replaced by ERCP & MRCP replaced by ERCP & MRCP DIAGNOSIS DIAGNOSIS Stone Stone   smooth crescent, filling defect smooth crescent, filling defect Stricture Stricture   smooth tapered CBD smooth tapered CBD CBDT CBDT   irreg. defect irreg. defect Ca head Ca head   obst & dil. obst & dil. COMPS COMPS Peritonitis, he, cholangitis Peritonitis, he, cholangitis
  • 58. IMAGING & ENDOSCOPY IMAGING & ENDOSCOPY CBD filling defect (stone) CBD filling defect (stone) Choledochal Cyst Choledochal Cyst PTC
  • 59. IMAGING & ENDOSCOPY IMAGING & ENDOSCOPY  MRCP MRCP non invasive non invasive accurate diag. accurate diag. non operator dependent non operator dependent non therapeutic non therapeutic
  • 60. MRCP MRCP  Non Contrast Angiography Non Contrast Angiography  
  • 61. MRCP MRCP Excellent visualization of Excellent visualization of intra luminal lesions , as intra luminal lesions , as well as clear anatomical well as clear anatomical imaging imaging
  • 62. SPECIAL TESTS SPECIAL TESTS SPECIAL TESTS: SPECIAL TESTS:  if biochemical point to: if biochemical point to: parenchymal parenchymal  liver biopsy & immunof. liver biopsy & immunof. obst J.: obst J.:  US US  D dil i.hep D D dil i.hep D GB, CBD, panc,Liver GB, CBD, panc,Liver CT CT panc lesion, obese, gases panc lesion, obese, gases
  • 63. SPECIAL TESTS SPECIAL TESTS  If Dilated i.hep. Duct: If Dilated i.hep. Duct: PTC( PTC(coag profile,antibs) coag profile,antibs)  D & drain D & drain  Non dilated ducts or equivocal US Non dilated ducts or equivocal US ERCP + sphincterotomy or stone ERCP + sphincterotomy or stone removal removal
  • 64. Physical examination Physical examination  General : signs of liver cell failure General : signs of liver cell failure Spider naevi, palmer erythema,scanty axillary and pubic Spider naevi, palmer erythema,scanty axillary and pubic hair foetor hepaticus ,neurological changes hair foetor hepaticus ,neurological changes supraclavicular swelling(Virchow’s sign) scratch marks supraclavicular swelling(Virchow’s sign) scratch marks  Ascitis (associated ALD, Malignant) Ascitis (associated ALD, Malignant)  Hepatosplenomegaly Splenomegaly may be due to splenic Hepatosplenomegaly Splenomegaly may be due to splenic vein thrombosis secondary to pancreatic malignancy vein thrombosis secondary to pancreatic malignancy  Palpable Gall bladder ,Abdominal lump Palpable Gall bladder ,Abdominal lump
  • 65. Jaundice with distended palpable Gall bladder Periampullary/Ca head of pancreas Cholangiocarcinoma of lower CBD Carcinoma Gallbladder Jaundice without palpable gall bladder Choledocholithiasis (shrunken Gall bladder) Hilar cholangiocarcinoma Nodes at porta hepatis
  • 66. Courvoisier’s Law Courvoisier’s Law  If in a jaundiced patient,the gall bladder is palpable, the case is not of stone impacted in CBD for previous cholecystitis existed when stone was in the gall bladder rendered gall bladder fibrotic and incapable of dilatation
  • 67. Exceptions to Courvoisier’s law Exceptions to Courvoisier’s law  Double impaction Double impaction  Oriental Oriental Cholangiohepatitis Cholangiohepatitis  Earlier Earlier Cholecystectomy Cholecystectomy  Malignant nodes at Malignant nodes at Porta hepatis Porta hepatis
  • 68. Choledocholithiasi s Clinical Features Cholangitis: Pain,Fever Jaundice,Shock Cloudy Sensorium (Reynold’s Pentad) Backache due to pancreatitis acholic stools pruritus ,high colored urine malnutrition and weight loss Alkaline Phosphatase,raised liver Enzymes in Cholangitis Leukocytosis Real-Time Mode Ultrasound is the single most important Investigation
  • 71. Clinical classification Of Obstructive Clinical classification Of Obstructive Jaundice Jaundice ( (Benjamin Classification) Benjamin Classification)
  • 72. Type I: Complete obstruction Type I: Complete obstruction Classical symptoms with Classical symptoms with biochemical changes biochemical changes Tumors: Ca. head of Tumors: Ca. head of Pancreas Pancreas Ligation of the CBD Ligation of the CBD Cholangiocarcinoma Cholangiocarcinoma Parenchymal Liver Parenchymal Liver diseases diseases
  • 73. Type II: Intermittent obstruction Type II: Intermittent obstruction • • Symptoms and typical Symptoms and typical biochemical changes biochemical changes • • But jaundice may or may But jaundice may or may not be present not be present Choledocholithiasis Choledocholithiasis Periampullary tumor Periampullary tumor Duodenal diverticula Duodenal diverticula Choledochal Cyst Choledochal Cyst Papillomas of the bile duct Papillomas of the bile duct Intra biliary parasites Intra biliary parasites Hemobilia Hemobilia
  • 74. TYPE III: Chronic incomplete obstruction TYPE III: Chronic incomplete obstruction With or without classical symptoms but With or without classical symptoms but pathological changes are present in the pathological changes are present in the bile duct and liver bile duct and liver Strictures of the CBD Strictures of the CBD - Congenital - Congenital - Traumatic - Traumatic - Sclerosing cholangitis - Sclerosing cholangitis - Post radiotherapy - Post radiotherapy Stenosed biliary enteric anastamosis Stenosed biliary enteric anastamosis Cystic fibrosis Cystic fibrosis Chronic pancreatitis ERCP Chronic pancreatitis ERCP Stenosis of the Sphincter of Od Stenosis of the Sphincter of Od showing distal common showing distal common bile duct stricture bile duct stricture
  • 75. TYPE IV: Segmental Obstruction TYPE IV: Segmental Obstruction one or more segment of the intrahepatic biliary tract one or more segment of the intrahepatic biliary tract is obstructed is obstructed Traumatic Traumatic Sclerosing cholangitis Sclerosing cholangitis Intra hepatic stones Intra hepatic stones Cholangiocarcinoma Cholangiocarcinoma
  • 76. Pathophysiology Of Pathophysiology Of Obstructive Jaundice Obstructive Jaundice Obstructive Obstructive jaundice is a jaundice is a condition in which condition in which there is blockage of there is blockage of the flow of bile out the flow of bile out of the liver. This of the liver. This results in an results in an overflow of bile and overflow of bile and its by-products into its by-products into the blood, and bile the blood, and bile excretion from the excretion from the body is incomplete body is incomplete  Hepatic functions Hepatic functions - Protein synthesis - Protein synthesis, - , - Reticulo-endothelial function - Reticulo-endothelial function - Hepatic metabolism Coagulation defect.. Hepatic metabolism Coagulation defect..increased increased prothrombin time(Decreased absroption of fat solube prothrombin time(Decreased absroption of fat solube vitamins A,D,E, vitamins A,D,E,K K(decreased factor XI ,XII ,platelets) (decreased factor XI ,XII ,platelets)  Renal functions - Renal vasoconstriction - Renal functions - Renal vasoconstriction - Activation of complement system causing Activation of complement system causing peritubular peritubular and glomerular fibrin deposition leading to tubular and and glomerular fibrin deposition leading to tubular and cortical necrosis cortical necrosis  Cardiovascular effects -Decreased peripheral vascular Cardiovascular effects -Decreased peripheral vascular resistance - Bradycardia due to direct effect of bile resistance - Bradycardia due to direct effect of bile salts on SA node - Decreased cardiac contractability salts on SA node - Decreased cardiac contractability Delayed wound healing due to defective synthesis of Delayed wound healing due to defective synthesis of collagen collagen
  • 77. ROUTINE ROUTINE Investigations Investigations  Haemoglobin usually decreased in case of malignancy Haemoglobin usually decreased in case of malignancy  • • Rfts are usually arranged Rfts are usually arranged
  • 78. BIOCHEMICAL PROFILE BIOCHEMICAL PROFILE 1. Conjugated bilirubin> increased 1. Conjugated bilirubin> increased 2. Urine bilirubin + 2. Urine bilirubin + 3. Urobilinogen will be absent 3. Urobilinogen will be absent 4. S.ALK PHOSPH RAISED 4. S.ALK PHOSPH RAISED (most sensitive, levels are (most sensitive, levels are elevated in nearly 100 % of patients with extrahepatic obstruction elevated in nearly 100 % of patients with extrahepatic obstruction except in some cases of intermittent obstruction. Values are except in some cases of intermittent obstruction. Values are usually greater than 3 times the upper limit of the reference usually greater than 3 times the upper limit of the reference range, and in most typical cases, they exceed 5 times the upper range, and in most typical cases, they exceed 5 times the upper limit) limit)
  • 79. BIOCHEMICAL PROFILE BIOCHEMICAL PROFILE 5. GAMMA–GLUTAMYL TRANSPEPTIDASE(GGT) is a 5. GAMMA–GLUTAMYL TRANSPEPTIDASE(GGT) is a sensitive marker of biliary tract disease is raised 6.5’nucleotidase sensitive marker of biliary tract disease is raised 6.5’nucleotidase is raised and it’s more specific is raised and it’s more specific 7. ALT AST may rise 7. ALT AST may rise 8. Albumin decreased 8. Albumin decreased 9 . PT prolonged clotting factor decreased 9 . PT prolonged clotting factor decreased 10. RFTs are usually impaired 10. RFTs are usually impaired
  • 80. Investigations Investigations Liver Function Tests Alk.Phos. Direct Hyperbilirubinemia Serum Proteins Normal Enzymes Absent Urobilinogen in urine Prolonged P.T.which returns to normal after Vit.K admin. Tumor markers like CA 19-9
  • 82. Radiology Radiology • IMAGING GOALS To confirm the presence of an extrahepatic obstruction  To determine the level of the obstruction, to identify the  specific cause of the obstruction To provide complementary information relating to the  underlying diagnosis (eg., Staging information in cases of malignancy). What is the best therapeutic approach? 
  • 83. – More sensitive than CT for gallbladder stones and other pathology of gallbladder – Sensitive for dilated ducts (Dilation of the extrahepatic (>10 mm) or intrahepatic (>4 mm) bile ducts suggests biliary obstruction.) – Liver parenchymal mass and Mets – Portable, cheap, no radiation, – But it is operator dependant -- Result is affected by bowel gas and Obesity. Ultrasound Abdomen Ultrasound Abdomen
  • 84. Spiral CT Scan Spiral CT Scan  Contrast-enhanced triple phase helical abdominal CT scan. This should be Contrast-enhanced triple phase helical abdominal CT scan. This should be carried out with thin cuts to provide arterial (3mm cuts) and venous phase (3 carried out with thin cuts to provide arterial (3mm cuts) and venous phase (3 or 5mm cuts) cross sectional imaging Hypo dense lesion ,Dilated CBD and or 5mm cuts) cross sectional imaging Hypo dense lesion ,Dilated CBD and PD with or without pancreatic mass PD with or without pancreatic mass  Accurate assessment of spread,involvement of vessels Hepatic mets free Accurate assessment of spread,involvement of vessels Hepatic mets free fluid False +ve (10%)focal pancreatitis ,sarcoidosis Tuberculosis, lymphoma fluid False +ve (10%)focal pancreatitis ,sarcoidosis Tuberculosis, lymphoma secondary tumors secondary tumors. .  MRI does not score over CT. Hypointense T1 weighted images,and Hyper MRI does not score over CT. Hypointense T1 weighted images,and Hyper intense T2 images. It detects vascular encasement. MRCP is can image the intense T2 images. It detects vascular encasement. MRCP is can image the CBD and PD without CBD and PD without cannulation cannulation
  • 85. CT SCAN CT SCAN Main role in malignant conditions Main role in malignant conditions mainly for localization of primary mainly for localization of primary tumors and mets tumors and mets • • Best for Pancreatic Best for Pancreatic Carcinoma(Highly sensitive for Carcinoma(Highly sensitive for lesion >1mm) lesion >1mm) • •Mainly done when ultrasound Mainly done when ultrasound fail or when there is ductal fail or when there is ductal dilation on ultrasound also to find dilation on ultrasound also to find level and cause of obstruction and level and cause of obstruction and in malignant conditions in malignant conditions
  • 86. MAGNETIC RESONANCE MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP) CHOLANGIOPANCREATOGRAPHY (MRCP) • • Noninvasive test to visualize Noninvasive test to visualize the hepatobiliary tree the hepatobiliary tree • • Entire biliary tree and Entire biliary tree and pancreatic duct can be seen pancreatic duct can be seen • • Best for Intra Hepatic stones Best for Intra Hepatic stones and CHOLEDOCHAL cysts and CHOLEDOCHAL cysts • • SINGLE BEST FOR SINGLE BEST FOR CHOLANGIOCARCINOMA CHOLANGIOCARCINOMA • • MRCP is better to determine MRCP is better to determine the extent and type of tumor as the extent and type of tumor as compared to ERCP compared to ERCP
  • 87. Endoscopic retrograde cholangiogram Endoscopic retrograde cholangiogram (ERCP) (ERCP)  Its an invasive Its an invasive procedure and has procedure and has therapeutic potential therapeutic potential. .  Allows biopsy or brush Allows biopsy or brush cytology cytology  Stone extraction or Stone extraction or stenting It’s stenting It’s
  • 88. Endoscopic retrograde cholangiogram Endoscopic retrograde cholangiogram (ERCP) (ERCP)  COMPLICATIONS COMPLICATIONS  Pancreatitis Pancreatitis Cholangitis Cholangitis Hemorrhage Hemorrhage Sepsis Sepsis   CONTRAINDICATIONS CONTRAINDICATIONS Unfav anatomy Unfav anatomy  Pseudocyst Pseudocyst Rec a/c pancreatitis Rec a/c pancreatitis
  • 89. ERCP vs MRCP ERCP vs MRCP  Routine ERCP may not be required if diagnosis is certain on CT scan Routine ERCP may not be required if diagnosis is certain on CT scan  ERCP can provide direct visualization of ampullary tumor and biopsy can be ERCP can provide direct visualization of ampullary tumor and biopsy can be taken taken  Preop biliary drainage is required as a therapeutic measure under following Preop biliary drainage is required as a therapeutic measure under following circumstances circumstances  Severe cholangitis Severe cholangitis  Patients whose surgery is delayed due to sepsis ,abnormal coaglation or Patients whose surgery is delayed due to sepsis ,abnormal coaglation or malnutrition malnutrition  a mode of palliation for obstructive jaundice. a mode of palliation for obstructive jaundice.  MRCP gives information about site of obstruction without injection of contrast MRCP gives information about site of obstruction without injection of contrast  No therapeutic potential, no tissue diagnosis is possible No therapeutic potential, no tissue diagnosis is possible
  • 90. Percutaneous Percutaneous Transhepatic Transhepatic Cholangiogram (PTC) Cholangiogram (PTC) • • PTC is indicated when PTC is indicated when percutaneous intervention percutaneous intervention is needed and ERCP either is needed and ERCP either is inappropriate or has is inappropriate or has failed. failed. • • Can be used to drain Can be used to drain biliary obstructions. biliary obstructions.
  • 91. Other Investigations Other Investigations  • • Oral Cholecystography (OCG)>>> Oral Cholecystography (OCG)>>> useful when patient has useful when patient has symptoms of cholelithiasis, but a negative ultrasound. symptoms of cholelithiasis, but a negative ultrasound.  • • also is useful for counting the number of stones present. also is useful for counting the number of stones present.  • • HIDA SCAN- useful in a/c cholecystitis HIDA SCAN- useful in a/c cholecystitis, ,  • • DIAGNOSTIC LAPAROSCOPY- DIAGNOSTIC LAPAROSCOPY-  • • ANGIOGRAPHY- abnormal vasc.anatomy ANGIOGRAPHY- abnormal vasc.anatomy  • • Tumor markers- CA19-9 , CEA Tumor markers- CA19-9 , CEA
  • 92. Endoscopic Ultrasound Endoscopic Ultrasound  Much Superior to Conventional CT & comparable with Much Superior to Conventional CT & comparable with Latest Generation spiral CT Latest Generation spiral CT  Can differentiate small stone from tumor in periampullary Can differentiate small stone from tumor in periampullary region region  Biopsies are possible Biopsies are possible  Highly Operator dependent,costly Highly Operator dependent,costly  Echoendoscope is bigger hence uncomfortable for the Echoendoscope is bigger hence uncomfortable for the patient patient  It is mainly useful for pancreatic imaging and biopsies It is mainly useful for pancreatic imaging and biopsies assessment of nodal involvement & Vascular encasement assessment of nodal involvement & Vascular encasement  Prior to endoscopic treatment of pseudocysts. Prior to endoscopic treatment of pseudocysts.
  • 93. Biopsy not possible Biopsy Possible
  • 96. Management of Obstructive Management of Obstructive Jaundice Jaundice
  • 97. Initial Evaluation: History Initial Evaluation: History  Jaundice, acholic stools, tea-colored urine Jaundice, acholic stools, tea-colored urine  Fever/chills, RUQ pain (cholangitis) Fever/chills, RUQ pain (cholangitis)  Could lead to life-threatening septic shock Could lead to life-threatening septic shock  Reasons to have hepatitis or cirrhosis? Reasons to have hepatitis or cirrhosis?  Alcohol, Viral, risk factors for viral hepatitis Alcohol, Viral, risk factors for viral hepatitis  Exposure to toxins or offending drugs Exposure to toxins or offending drugs  Inherited disorders or hemolytic conditions Inherited disorders or hemolytic conditions  Recent blood transfusions or blood loss? Recent blood transfusions or blood loss?  Is patient septic or on TPN? Is patient septic or on TPN?  Recent gallbladder surgery? (CBD injury) Recent gallbladder surgery? (CBD injury)
  • 98. Initial Evaluation: Physical Exam Initial Evaluation: Physical Exam  Signs of end stage liver disease (cirrhosis) Signs of end stage liver disease (cirrhosis)  Ascites, splenomegaly, spider angiomata, and Ascites, splenomegaly, spider angiomata, and gynecomastia gynecomastia  Jaundice evident first underneath the tongue, Jaundice evident first underneath the tongue, also evident in sclerae or skin also evident in sclerae or skin  Courvoisier’s sign = painless, but palpable or Courvoisier’s sign = painless, but palpable or distended gallbladder on exam distended gallbladder on exam  Could indicate Could indicate malignant malignant obstruction obstruction
  • 99. Perioperative management of obstructive Perioperative management of obstructive jaundice jaundice  • • Preoperative biliary decompression improves postoperative morbidity Preoperative biliary decompression improves postoperative morbidity (usually causes increased hemorrhage & infections and is mainly Indicated in (usually causes increased hemorrhage & infections and is mainly Indicated in severe jaundice or when there are signs of impending liver failure. Endoscopic severe jaundice or when there are signs of impending liver failure. Endoscopic internal drainage is preferred over per-cutaneous external drainage internal drainage is preferred over per-cutaneous external drainage  • • Intravenous administration of 5% dextrose saline followed by Intravenous administration of 5% dextrose saline followed by 10%mannitol or loop diuretics to prevent renal failure(12 to 24 hours 10%mannitol or loop diuretics to prevent renal failure(12 to 24 hours prior to surgery) prior to surgery)  • • catheterization to monitor output catheterization to monitor output  • • Broad spectrum antibiotic prophylaxis Broad spectrum antibiotic prophylaxis  • • Parenteral vitamin K +/- fresh frozen plasma Parenteral vitamin K +/- fresh frozen plasma  • • Need careful post-operative fluid balance to correct dehydration Need careful post-operative fluid balance to correct dehydration  • • Correction of hypokalemia Correction of hypokalemia  • • Cholestyramine and antihistamine for symptomatic relief of pruritis Cholestyramine and antihistamine for symptomatic relief of pruritis
  • 100. Summary of Treatment of Summary of Treatment of Obstructive Jaundice Obstructive Jaundice based on the cause based on the cause
  • 101. Treatment of Obstructive Jaundice is Treatment of Obstructive Jaundice is based on the cause based on the cause 1) Cholelithiasis (gallstones 1) Cholelithiasis (gallstones) ) Ideally ERCP followed by laparoscopic Ideally ERCP followed by laparoscopic Cholecystectomy Or open cholecystectomy with Cholecystectomy Or open cholecystectomy with CBD exploration CBD exploration
  • 102. 2) Ca Head of Pancreas / Periampullary 2) Ca Head of Pancreas / Periampullary Carcinoma/malignancy Carcinoma/malignancy of lower 3rd of CBD of lower 3rd of CBD a) Whipple resection a) Whipple resection (pancreaticoduodenectomy) is (pancreaticoduodenectomy) is mainly done which involves mainly done which involves removal of the removal of the head & neck of head & neck of pancreas, duodenum, distal pancreas, duodenum, distal 40% of the stomach, lower 40% of the stomach, lower CBD, GB, upper 10 cm of CBD, GB, upper 10 cm of jejunum, regional L.Ns, and jejunum, regional L.Ns, and reconstruction through reconstruction through gastrojejunostomy, gastrojejunostomy, choledochojejunostmy and choledochojejunostmy and pancreaticojejunostomy pancreaticojejunostomy b) If not operable then we go for Endoscopic sphincterotomy + stenting with Percutaneous transhepatic biliary drainage
  • 103. 3) Ca gall bladder a) if involving cbd then Whipple resection is done b) And in case of inoperable cases Endoscopic / Radiological stenting is done 4) Choledochal cyst  Surgical excision of the cyst with Reconstruction of the extrahepatic biliary tree  Biliary drainage is accomplished by Choledocho– jejunostomy with a Roux – en – Y anastomosis  Long-term follow-up is necessary because of complications like cholangitis, lithiasis, anastomotic stricture
  • 104. 5) Cholangiocarcinoma 5) Cholangiocarcinoma Surgery depends on the stage of the tumor and may involve Surgery depends on the stage of the tumor and may involve Removal of the bile ducts Removal of the bile ducts If the tumor is at a very early stage (Stage 1), just If the tumor is at a very early stage (Stage 1), just the bile ducts containing the cancer are removed. The remaining ducts in the the bile ducts containing the cancer are removed. The remaining ducts in the liver are then joined to the small bowel, allowing the bile to flow again. liver are then joined to the small bowel, allowing the bile to flow again. Partial liver resection Partial liver resection If the tumor has begun to spread into the liver, the If the tumor has begun to spread into the liver, the affected part of the liver is removed, along with the bile ducts. affected part of the liver is removed, along with the bile ducts. Whipple procedure Whipple procedure If the tumor is larger and has spread into nearby If the tumor is larger and has spread into nearby structures, the bile ducts, part of the stomach, part of the small bowel structures, the bile ducts, part of the stomach, part of the small bowel (duodenum), the pancreas, gall bladder, and the surrounding lymph nodes are (duodenum), the pancreas, gall bladder, and the surrounding lymph nodes are all removed all removed If surgery to remove the tumor is not possible If surgery to remove the tumor is not possible, it may be possible to , it may be possible to relieve the blockage through stents through ERCP or PTC relieve the blockage through stents through ERCP or PTC
  • 105. 6)Choledocholithiasis 6)Choledocholithiasis (stones in the CBD) (stones in the CBD) a)Treatment of choice is stone extraction through ERCP a)Treatment of choice is stone extraction through ERCP b) b) Mechanical lithotripsy – through modified Dormia basket Mechanical lithotripsy – through modified Dormia basket c)Through shock waves laser technology c)Through shock waves laser technology d)Open exploration of the common bile duct is indicated in d)Open exploration of the common bile duct is indicated in   Presence of multiple stones (more than 5) and Stones > 1 cm Presence of multiple stones (more than 5) and Stones > 1 cm  Multiple intrahepatic stones Multiple intrahepatic stones  Distal bile duct strictures Distal bile duct strictures  Failure of ERCP Failure of ERCP  Recurrence of CBD stones Recurrence of CBD stones
  • 106. 7)Strictures are usually treated by endoscopic stenting which is comparable to that of surgery, with similar recurrence rates. Therefore, surgery should probably be reserved for those patients with complete ductal obstruction or for those in whom endoscopic therapy has failed. Surgery with Roux-en-Y choledochojejunostomy or hepaticojejunostomy is the standard of care with good or excellent results in 80 to 90% of patients. 8) Stenosis of the Sphincter of Oddi endoscopic or operative sphincterotomy will yield good results
  • 107. Prognostic factors Prognostic factors ( Pitt’s score) ( Pitt’s score) Parameters Parameters Type of obstruction Type of obstruction (malignant or benign) (malignant or benign) Age > 60 yrs Age > 60 yrs S.Alb< 3gm/dl S.Alb< 3gm/dl S.Bil > 10mg% S.Bil > 10mg% S.Alk P > 100 IU S.Alk P > 100 IU S.Creatinine >1.3mg% S.Creatinine >1.3mg% TLC >10000/mm3 TLC >10000/mm3 Hematocrit < Hematocrit < 30% 30% Factors Mortality Factors Mortality Up to 2 0% Up to 2 0% 3 4% 3 4% 4 7% 4 7% 5 44% 5 44% 6 67% 6 67% 8 100% 8 100%
  • 108. Choledocholithiasis known before Surgery Clear the common bile duct with an initial Endoscopic papillotomy followed by laparoscopic cholecystectomy. Open Cholecystectomy with common bile duct exploration. Lap. Chole with Lap CBD Exploration History & Pre-op. Investigations Therapeutic Options
  • 109. Choledocholithiasis Identified during Cholecystectomy. (1) Conversion to an open operation with Common bile duct exploration, (2) Laparoscopic common bile duct exploration, (3) completion of the laparoscopic cholecystectomy with postoperative endoscopic sphincterotomy and stone extraction Lap.U.S. Cholangiogram Transcystic Choledochoscopy Therapeutic Options
  • 110. Choledocholithiasis Identified After Cholecystectomy. Theses patients are best managed with endoscopic sphincterotomy and stone extraction. If a T tube is still present from a recent common bile duct exploration radiologic extraction of the stone via the T tube tract is usually possible Open Surgery is usually avoided Therapeutic Options
  • 111. Interventional Radiology For retrieving the stone from CBD by balloon Catheter
  • 112. Imaging for Obstructive Jaundice Imaging for Obstructive Jaundice  RUQ Ultrasound RUQ Ultrasound  See stones, CBD diameter See stones, CBD diameter  CT scan CT scan  Identify both type & level of obstruction Identify both type & level of obstruction  ERCP ERCP  Direct visualization of biliary tree/panc ducts Direct visualization of biliary tree/panc ducts  Procedure of choice for choledocholithiasis Procedure of choice for choledocholithiasis  Diagnostic –AND- therapeutic (unlike MRCP) Diagnostic –AND- therapeutic (unlike MRCP)  PTC useul of obstruction is prox to CHD PTC useul of obstruction is prox to CHD  Endoscopic Ultrasound or EUS Endoscopic Ultrasound or EUS
  • 113. Extra-hepatic cholestasis: Extra-hepatic cholestasis: Pancreatic tumor Pancreatic tumor - - Tumor Detection Tumor Detection  Focal enlargement of the gland Focal enlargement of the gland  Hypodense mass on enhanced CT Hypodense mass on enhanced CT Secondary signs Secondary signs: :  Mass effect or convex contour abnormality Mass effect or convex contour abnormality  Atrophic distal pancreatic parenchyma Atrophic distal pancreatic parenchyma  Dilatation of CBD and MPD in the absence of obstructive Dilatation of CBD and MPD in the absence of obstructive calculus (interupted duct sign) calculus (interupted duct sign)
  • 114. Extra-hepatic cholestasis: Extra-hepatic cholestasis: Ampulary tumor Ampulary tumor  Malignant epithelial tumor , ampula of vater Malignant epithelial tumor , ampula of vater  Presents with jaundice, weight loss. Abd or Presents with jaundice, weight loss. Abd or back pain back pain  Age: mean 65 yrs, no sex predeliction Age: mean 65 yrs, no sex predeliction  Prognosis: depends on nodeal status and Prognosis: depends on nodeal status and differentiation of tu, better than panc ca differentiation of tu, better than panc ca 5 yrs- 38% if resected 5 yrs- 38% if resected Treatment: Whipple if pos. Treatment: Whipple if pos.
  • 115. Extra-hepatic cholestasis: Extra-hepatic cholestasis: Ampulary tumor Ampulary tumor  Imaging: Imaging:  Lobulated soft tissue mass at ampula Lobulated soft tissue mass at ampula  “ “Double duct” sign Double duct” sign  CT: Hypodense mass , distention of du helpful CT: Hypodense mass , distention of du helpful
  • 116. Extra-hepatic cholestasis: Extra-hepatic cholestasis: Cholangiocarcinoma Cholangiocarcinoma  US: dilated BD, mass hyperechogenic(75%) US: dilated BD, mass hyperechogenic(75%)  CT: hypodense mass, IHBD dilatation, rim CT: hypodense mass, IHBD dilatation, rim enhancement with prog central patchy enhancement with prog central patchy enhancement, persistent enhancement on enhancement, persistent enhancement on delayed scan delayed scan
  • 117. Extra-hepatic cholestasis: Extra-hepatic cholestasis: Gallstone disease  15%-20% of the population 15%-20% of the population  Passage of gallstones through Passage of gallstones through biliary system causes -----> biliary system causes ----->  Biliary colic Biliary colic  Acute cholecystitis Acute cholecystitis  Choledocholithiasis Choledocholithiasis  Cholecystoenteric fistula Cholecystoenteric fistula
  • 118. Biliary stone disease - summary Biliary stone disease - summary  US is the modality of choice for demonstrating gallstones. US is the modality of choice for demonstrating gallstones.  US is the very good for demonstrating biliary ducts. US is the very good for demonstrating biliary ducts.  CT will show biliary ducts, less reliable for filling defects. Good CT will show biliary ducts, less reliable for filling defects. Good for neoplastic disease. for neoplastic disease.  MRCP is the non invasive study MRCP is the non invasive study  ERCP is invasive but potentially therapeutic. ERCP is invasive but potentially therapeutic.  PTC even more invasive, when ERCP is limited. PTC even more invasive, when ERCP is limited.
  • 119. Extra-hepatic cholestasis: Extra-hepatic cholestasis: Cholelithiasis Cholelithiasis  Sensitivity 90%-95% Sensitivity 90%-95%  Variable SI Variable SI  Water/lipids contents Water/lipids contents  Elevated SI on T2 in Elevated SI on T2 in center ( center (  50%) 50%) Elevated SI on T1 ( Elevated SI on T1 (  90%) 90%) Co Co, Fe, Mg , Fe, Mg (pigmented gallstones (pigmented gallstones [Ca [Ca++ ++ Bilirrubinate]) Bilirrubinate]) Ukaji M Ukaji M et al. et al. Eur J Radiol 2002 Jan;41(1):49-56 Eur J Radiol 2002 Jan;41(1):49-56
  • 126. ERCP : ERCP : Stone extraction Stone extraction
  • 127. Choledocholithiasis Choledocholithiasis  Asymptomatic Asymptomatic  Symptoms: calculi in distal CBD (90%) Symptoms: calculi in distal CBD (90%)  CBD stones CBD stones  15% pts. with gallstones 15% pts. with gallstones  15% pts. with acute cholecystitis 15% pts. with acute cholecystitis  Diagnosis pre laparoscopic cholecystectomy Diagnosis pre laparoscopic cholecystectomy  ERCP ERCP  Stones in only 27-50% of pts with clinical suspicion Stones in only 27-50% of pts with clinical suspicion
  • 128. Choledocholithiasis MR Choledocholithiasis MR  Normal CBD Normal CBD  98% of the pts 98% of the pts  Foci of low SI surrounded by Foci of low SI surrounded by bright bile (T2-WI) bright bile (T2-WI)  Stones Stones   2 mm 2 mm  CBD stones CBD stones  Sensitivity 85-100% Sensitivity 85-100%  Specificity 90-99% Specificity 90-99%  Accuracy 89-97% Accuracy 89-97%  PPV 77-93% PPV 77-93%  NPV 94-100% NPV 94-100%
  • 129. Retrograde Cholangiogram - ERCP Retrograde Cholangiogram - ERCP Bile leak from the cystic duct after cholecystectomy Courtesy of Michael Kimmey, M.D.
  • 130. Primary sclerosing cholangitis (PSC) with stricture due to cholangiocarcinoma. Courtesy of Robert L. Carithers, Jr., M.D. Retrograde Cholangiogram - ERCP Retrograde Cholangiogram - ERCP
  • 131. Primary Sclerosing Cholangitis Primary Sclerosing Cholangitis Normal Extra hepatic BD Narrowed abnormal intra-heptic bile ducts.
  • 132. Irregular dilation of intrahepatic and extrahepatic ducts. Courtesy of Charles Rohrmann, M.D. Retrograde Cholangiogram - ERCP Retrograde Cholangiogram - ERCP
  • 133. Biliary tree imaging modalities: ERCP, Biliary tree imaging modalities: ERCP, MRCP, PTC MRCP, PTC  MRCP –specific MR MRCP –specific MR sequence is employed sequence is employed to demonstrate the to demonstrate the biliary tree. biliary tree.  No IV contrast and No IV contrast and definitely no biliary definitely no biliary cannulation involved. cannulation involved.
  • 134. Magnetic Resonance Cholangio- Magnetic Resonance Cholangio- Pancreatography (MRCP) Pancreatography (MRCP) Two stones in the common bile duct Two stones in the common bile duct Courtesy of Udo Schmiedl, M.D. Courtesy of Udo Schmiedl, M.D.
  • 135. Biliary tree imaging modalities: ERCP, Biliary tree imaging modalities: ERCP, MRCP, PTC MRCP, PTC  PTC – direct PTC – direct cannulation of the cannulation of the biliary tree, and biliary tree, and iodinated contrast iodinated contrast injection. injection.  Advantageous over Advantageous over MRCP for showing MRCP for showing distal, small duct distal, small duct pathology and pathology and walls irregularity. walls irregularity.
  • 136. PTC PTC Percutaneous access to Percutaneous access to the biliary tree, through the the biliary tree, through the CBD, if possible, and into CBD, if possible, and into the duodenum. the duodenum. Downsides: Downsides:  External drainage External drainage  Procedural risks: Procedural risks:  Coagulopathy Coagulopathy  ascites ascites
  • 139. Treatment of Choledocholithiasis: Treatment of Choledocholithiasis: Preoperative Preparation: Correct Clotting Dysfunction Guard vs LCF Guard vs RF Definitive Treatment: Remove Source of Obstruction (stone) Remove Source of Stone (Gall bladder) Reynold’s Pentad Obstructive Jaundice Charcot’s Triad Chronic cholecystitis Treatment ttt Of Shock 3 rd Generation Cephalosporin ERCP Cholecystectomy
  • 140. Carcinoma of head of pancreas Symptoms Signs Cachecxia Criteria of obstructive jaundice Pain which is common, characterized by starting as vague (Lower abdomen or back) Usually worsen in supine position & relived by lining forward It may be caused by : A) Tumor invasion of splanchnic plexuses & retroperitoneum B) Obstruction of pancreatic duct Digestive symptoms Jaundice Palpable liver Palpable gall bladder Tenderness Ascites Abdominal mass In advanced cases : Nodular liver Enlarged supraclavicular lymph node Periumblical adenopathy
  • 141. Diagnosis & management of pancreatic cancer : It depends on results of Spiral CT 1 ) Resectable: ask yourself if operative candidate or not a)YES :Explore for resection b) NO: =NONOPERATIVE: Palliation, Biliary stent & Chemo/Radiotherapy 2 ) Unresectable: is it only Biliary or associated with duodenal obstruction a)only Biliary:Endobiliary stent b)Both: Operative palliation(Biliary bypass) Gastrojejunostomy Celiac plexus block
  • 144. Conclusion Conclusion • • There are certain signs and symptoms common to all jaundiced patients (yellow There are certain signs and symptoms common to all jaundiced patients (yellow skin, itching). skin, itching). • • Specific items from the history and physical examination along with blood work Specific items from the history and physical examination along with blood work can help the clinician classify jaundice into obstructive and nonobstructive can help the clinician classify jaundice into obstructive and nonobstructive jaundice. jaundice. • • Surgical or other mechanical intervention almost exclusively is restricted to cases Surgical or other mechanical intervention almost exclusively is restricted to cases of obstructive (posthepatic) jaundice. of obstructive (posthepatic) jaundice. • • Imaging evaluation of the gallbladder and biliary system plays an important role Imaging evaluation of the gallbladder and biliary system plays an important role in the evaluation of obstructive jaundice by locating the site and disclosing the in the evaluation of obstructive jaundice by locating the site and disclosing the nature of the obstruction. nature of the obstruction. • • Ultrasound imaging usually is the first step for suspected biliary stone disease. Ultrasound imaging usually is the first step for suspected biliary stone disease. • • The physician’s level of suspicion about benign versus malignant causes of The physician’s level of suspicion about benign versus malignant causes of obstructive jaundice will lead to different radiologic tests and interventions. obstructive jaundice will lead to different radiologic tests and interventions. • • Treatment is tailored to the cause of obstruction Treatment is tailored to the cause of obstruction. .

Editor's Notes

  • #113: זיהוי הגידול: רדיולוגיה מבוססת על היגיון. מחפשים הגדלת אזור הלבלב ומסה היפודנסית לפני ההזרקה וגם אחרי ההזרקה של חומר ניגוד. אם הגידול מאוד קטן או איזו-דנסי – שני הסימנים אינם מתקיימים ומחפשים סימנים משניים: שינוי ב-contour של הלבלב – אנשים אלה מבוגרים יותר, והלבלב בהם עובר הסננה של שומן בנורמה, למעט באזור הגידול, שהוא יותר בשרני ומוצק. הגידול חוסם את ניקוז הלבלב, כך שנוצרת אטרופיה באזור שאינו יכול להתנקז, זהו האזור המרוחק המנוקז ע"י ה-pancreatic duct. הרחבה של צינור המרה וצינור הלבלב הראשי.
  • #114: Extra-hepatic cholestatsis – גידול ב-ampula אם הלבלב תקין, יש סיכוי שזהו גידול באמפולה של vater בתרסריון. גם אז הכאב יופיע בבטן, כמו במקרה הקודם. הפרוגנוזה אינה טובה, וגם הטיפול דומה לסרטן הלבלב – ניתוח whipple.
  • #115: רואים קרצינומה בראש התרסריון, וכך זה נראה באנדוסקופיה.
  • #117: רואים פה MRI במבט קורונארי (רגלים למטה) – האיש שמן עם הרבה שומן תת-עורי, רואים לב, טחול ומשהו ענק ולבן בתוך כיס המרה ואבן. בנורמה: נוזל ב-US הוא שחור, כי אינו מחזיר גלי קול, ולכן הוא unechoic - כיס המרה מכיל נוזל שחור, כאילו ציירו בעיפרון. אפשר לבדוק גופנית – ללחוץ ישירות על כיס המרה עם המתמר ולראות אם זה כואב – סימן murphy's sonography. כיס מרה שמכיל אבנים: האבנים לבנות, כי מחזירות גלי קול רבים, ולא נותנות להם לעבור דרכם. מאחוריהן האות שחור, כי האות נבלע ע"י האבנים ולא חוזר למכשיר. שני החולים מראים כיס מרה ברוחב תקין (לא תפוח), מכיל נוזל שחור ותקין והאבנים הן פס עדין ודק. זהו לא כיס מרה עם דלקת חריפה או cholecysticis. רואים חלק מהכבד, כליה, חלק מהקיבה, תרסריון, חתיכה מהלבלב וכיס המרה שיושב בשקט – עם שומן תקין, אין הסננה בתוכו ואין עכירות. לא רואים דופן, אבל רואים דופן מסויידת. ה-CT מזהה רק אבנים מסויידות, ופחות טוב בזיהוי אבני כולסט' לא מסויידות ולכן US יותר טוב ממנו. US טוב לזיהוי דרכי המרה – הולכות יחד עם ה-portal vein. רואים את ה-common bile duct. נבחין ביניהם ע"י דופלר – הוא צובע את כלי הדם (כיוון שהוא זז, והוא מקבל צבע לפי כיוון תנועתו: כחול – דם שנע אחורה מהמתמר, אדום – דם שנע לכיוון המתמר). רואים את ה-IVC והכבד, והצינור השחור יכול להיות עורק הכבד או ה-common bile duct – הווריד הפורטאלי נצבע בנקודה אדומה, והדבר הזה לא מקבל שום צבע – אז זה ה-common bile duct. רואים: וריד השער, עורק הכבד ודרכי מרה מאוד מורחבות. רואים את הכבד. ב-US האנטומיה יותר ברורה מ-CT, כי יש תמונות אלכסוניות ולא אנטומיות. רואים למעלה משמאל – סרעפת (פס לבן), דרכי המרה מורחבות. גם מימין דרכי המרה מורחבות. אבנים יכולות להיות בתוך דרכי המרה וה-US יכול להדגים אותן עם עברו מכיס המרה ל-cystic duct – רואים אבן של 1-2 ס"מ (למטה), כיס מרה עם אבנים (מימין). Approximately 15 to 20% of the population in the US has gallstones When this gallstones pass into the biliary system, the pt can present with a spectrum of clinical conditions that varies from the self-limiting biliary colic to the complicated forms of acute cholecystitis depending on the location and duration of the obstruction.
  • #118: .
  • #119: .
  • #134: דרכי מרה מורחבות מאוד (במרכז) לעומת דרכי המרה התקינות (משמאל). רואים פגם מילוי בדרכי המרה שהוא אבן. מימין פגם מילוי גדול בשל כמה אבנים.